Ohio State Navbar

Directory

More About Dr. Toland


Staff photo

460 W 12th Ave
Columbus, OH 43210

Phone: (614) 247-8185

Email: toland.13@osu.edu

 

Current OSU Appointments

Associate Professor, SBS-Molec Vir, Imm & Med Gen

Associate Professor, Human Genetics

 

Biographical

I received my PhD in Human Genetics in 1996 from the Unversity of Utah, Salt Lake City in the laboratory of Dr. Mark T Keating. The title of my dissertation was, "The Molecular Genetics of Williams Syndrome". During my dissertation I identified a microdeletion which causes a rare syndrome called Williams Syndrome. My dissertation work led to many first author papers including a first author Nature Genetics paper. I also was a contributing author on two Cell papers. In 1996, I began a three year clinical fellowship in PhD Medical Genetics and Clinical Molecular Genetics at the UCSF Medical Genetics Training Program headed by Dr. Charles Epstein. As part of my clinical fellowship, I also performed basic research in the laboratory of Dr. Farid Chehab. The focus of my research studies was identification of modifier genes of fertility in obese mice. This work led the the identification of several loci important for infertility in obese mice. In 1999, following my clinical training, I became certified by the American Board of Medical Genetics in PhD Medical Genetics and Clinical Molecular Genetics. Also in 1999, I started a postgraduate fellowship in the laboratory of Dr. Allan Balmain to study cancer genetics and I continued my clinical work by serving as a Medical Geneticist for the UCSF Cancer Risk program. My research work with Dr. Balmain led to the identification of a skin cancer susceptibility gene for mouse and humans. These findings resulted in a first author Nature Genetics paper and serve as the basis of one of the current projects in the lab. In July 2005, I became an Assistant Professor at the Ohio State University in the Department of Molecular Virology, Immunology and Medical Genetics with a joint appointment in the Division of Human Genetics, Department of Internal Medicine. In October 2011, I was promoted to Associate Professor with tenure.

Clinical Interest

Cancer Genetics

Advising Narrative

Andrew Spearman: Received Mayers Summer Research Internships (Summer 2006 and 2007; 1 of 10 awards). Received Phi Kappa Phi Undergraduate Enrichment Award (2007; 1 of 2 awards)Received College of Arts and Sciences Scholarship for undergraduate research (Winter and Spring 2008)Received Dean’s Undergraduate Research Award in Biological Sciences (Spring 2008).Completed his honors thesis (Spring 2008) First author manuscript in the Journal of Clinical Oncology (2008).Currently pediatrics resident at the University of Chicago.



Stephanie Tseng: Author on two published manuscripts, including one second author paper. Received Mayers Summer Research Internship (Summer 2008).Received an ASC Undergraduate Research Scholarship (Winter/Spring 2009). Presented at the Denman Undergraduate Research Forum (May 2009 and May 2010).Mortar Board Honor Society. Currently 3rd year medical student at New York University Medical School.



Nick Gladman: (Summers only)Contributing author on a paper published in BMC Genomics. Currently a graduate student at the University of Wisconsin Madison.



Dustin Gable: Poster presenter at the OSUMC Research Day (Spring 2009 and 2010) Presented at Denman undergraduate research forum (Spring 2009 and 2010) Grever Summer Fellowship (Summer 2009). Presented at the 20th Annual Argonne Symposium for Undergraduates in Science, Engineering, and Mathematics conference in Chicago, IL (Autumn 2009). Won a travel award to attend the Cullen Trust for Higher Education Symposium on Translational Research and MD/PhD Career Development Workshop to be held at the Texas Medical Center in Houston (2009). Awarded a research summer fellowship at St. Jude's (Summer 2010).OSU finalist for a Goldwater Scholarship (Autumn 2009) and 2010 Barry M. Goldwater Scholars (Spring 2010) AACR-Thomas J Bardos Science Education Award for Undergraduate Students (2010; 2 year award) Oral presentation for 2010 OSUMC Research DayBest undergraduate poster 2010 OSUMC Research Day2010 Denman Undergraduate Research Forum Best Poster Health Professions Laboratory/Cellular Division. Poster presenter annual American Society of Human Genetics Meeting, Washington DC (November 2010). Currently MD/PhD program at Johns Hopkins.



Kelsey Gray: October 2010,2011 Presented at Sigma Xi undergraduate research symposium, North Carolina. Winner in the undergraduate student division of the 2010 Ohio State Chapter of Sigma Xi's Grants-in-Aid of Research competition. Poster presenter at OSUMC Research Day (2010, 2011, 2012)Poster presenter at Denman Undergraduate Research Forum (2010, 2011, 2012). Awarded Undergraduate Pelotonia Fellowship (2010-2011). National Science Foundation graduate fellowship recipient (2012). Currently graduate student at University of North Carolina.



Tyler Siekmann: Awarded Undergraduate Pelotonia Fellowship (2012-2013). Awarded Grever Fellowship (2012). Second place poster Professional Laboratory/Cell Divison Denman Undergraduate research forum (2013). Denman Undergraduate Research Forum poster presenter (2013).



Luke Cheng: Awarded Academic Enrichment grant for research in the lab (2013). Sigma Xi fellowship for research in lab (2014).

Published Works

Since my appointment as an Assistant Professor at OSU in 2005, I have 47 in press or published works which include 42 peer-reviewed articles, one editor reviewed article, 4 book chapters and one encylopedia entry. I am corresponding author of 22 of these publications. Publications of note from my group include an article that is currently in press in PLoS Genetics. This publication showed for the first time that the somatic events in independent cutaneous SCCs arising within an individual are more similar than somatic events occuring in SCCs from unrelated individuals. In addition, we showed evidence that some somatic events are allele specific. In 2008, I published work in the high impact journal, The Journal of Clinical Oncology. In this article we describe a new predictive algorithm to classify BRCA1 and BRCA2 variants of uncertain significance. This was work nearly entirely carried out in my laboratory. We are using our algorithm to develop a web-based application for clinical use. My laboratory also made an exciting finding showing that a newly discovered polyomavirus, Merkel Cell Polyomavirus, is present in about 20% of skin squamous cell carciomas. This work was published in 2009 in the Journal of Investigative Dermatology, the top cited journal in the field of Dermatology, and was cited online in a website for exciting discoveries in dermatology. I am corresponding author of a review article written with Tim Huang and published in Cancer Research in 2008 on an exciting new area of science--Transgenerational Inheritance of Epigenetic Changes.

Research Funding

Funding amounts are listed as annual direct costs except when noted in the description of the grant. For pending grants, "amount funded" is annual direct costs in the budget. If the amount varies from year to year, the amount for the first year is listed. For multi-PI grants, the amount listed is the money in the budget for our laboratory and collaborators.

Master/Graduate Advising

I currently am dissertation advisor to one graduate student. My first graduate student completed her doctoral degree in March 2010 and completed at postdoctoral fellow at the NIH. She currently works as research liason for the CCTS at OSU. My second graduate student completed her doctoral degree in December 2012 and is working on a postdoctoral fellowship in the Chakavarati lab.



I was on the dissertation committee for Dr. Brian Wulff who graduated in 2008, Urmilla Santanam who graduated in 2010, Daniel Deatherage who graduated in 2010 and Courtney Nichols who graduated in 2012. I currently serve as a dissertation committee member for Zeina Kais, Erin Burns, Jonathan Sanford, Muhtadi Islam, Elizabeth Barrie, Kelly Nye, Hui-Wen Liu, Cindy Lee, Alaina Martinezy and Adam Suhy.



I have served as honors thesis advisor to four undergraduate students and have served as a committee member on two honors undergraduate thesis examination.



I have served as graduate faculty representative for three exams: one candidacy exam (2006) and five general dissertation examinations (2007, 2009, 2010, 2011, 2012).

Academic Advising

2009 - present Kelsey Gray The Ohio State University. Graduated 2012. Functional analysis of DcpS as a candidate cutaneous squamous cell carcinoma susceptibility gene
2010 - present Zeina Kais The Ohio State University.
2011 - present Madelyn Gerber The Ohio State University.
2011 - present Elizabeth Barrie The Ohio State University.
2011 - present Tyler Siekmann The Ohio State University.
2011 - present The Ohio State University.
2011 - present Jonathan Sanford The Ohio State University.
2011 - present Erin Burns The Ohio State University.
2012 - present Pooja Joshi The Ohio State University.
2012 - present Luke Cheng The Ohio State University.
2013 - present Alaina Martinez The Ohio State University.
2013 - present Matthew Cianciolo The Ohio State University.
2013 - present Jenna Karras The Ohio State University.
2013 - present Cindy Lee The Ohio State University.
2014 - present Rebecca Hennessey The Ohio State University.
2005 - 2006 Ryan McGrath The Ohio State University. Graduated 2006.
2006 Natalya Nazaryan The Ohio State University.
2006 Hee-Yeon Cho The Ohio State University. Graduated 2010.
2006 Anika Bhandari The Ohio State University.
2005 - 2008 Andrew Spearman The Ohio State University. Graduated 2008. Deciphering the Clinical Significance of BRCA Variants
2006 - 2008 Nicholas Gladman The Ohio State University. Graduated 2008.
2007 - 2008 Lindsey Moeller The Ohio State University. Graduated 2008.
2007 - 2008 Brian Wulff The Ohio State University. Graduated 2008. Effects of therapeutic immunosuppressants on UVB induced inflammation and skin carcinogenesis in a murine model.
2008 Stephanie Moormann The Ohio State University. Graduated 2011.
2009 Amber D'Souza The Ohio State University. Graduated 2012.
2006 - 2010 Amy Dworkin The Ohio State University. Graduated 2010. Environmental and Genetic Contributions of Susceptibility to Cutaneous Squamous Cell Carcinoma
2007 - 2010 Stephanie Tseng The Ohio State University. Graduated 2010. Identification of Squamous Cell Carcinoma Susceptibility Genes Using Homozygosity Mapping
2007 - 2010 Urmila Santanam The Ohio State University. Graduated 2010. Role of microRNA-29 in the pathogenesis of B-cell chronic lymphocytic leukemia
2010 Somayeh Samadzadeh The Ohio State University.
2010 Adam Suhy The Ohio State University.
2007 - 2011 Dustin Gable The Ohio State University. Graduated 2011. Ets1 as a target of microRNA-1 in cutaneous squamous cell carcinoma
2008 - 2011 Daniel Deatherage The Ohio State University. Graduated 2011.
2010 - 2011 Elizabeth Lin The Ohio State University.
2011 Elizabeth Patterson The Ohio State University.
2011 Nathan Schulz The Ohio State University.
2011 Sweta Kotian The Ohio State University.
2010 - 2012 Courtney Nicholas The Ohio State University. Graduated 2012. The Protein Arginine Methyltransferase PRMT5 Regulates Proliferation
2007 - 2013 Jessica Fleming The Ohio State University. Graduated 2012. Utilizing Cancer Resistant and Susceptible Mice to Identify the Genetic Contributions to Cutaneous Squamous Cell Carcinoma Susceptibility
2011 - 2013 Allison Nosoti The Ohio State University. Graduated 2013.
2011 - 2014 Hui-wen Liu The Ohio State University. Graduated 2014.
 

Certifications

1999 - present Clinical Molecular Genetics: American Board of Medical Genetics
1999 - present PhD Medical Genetics: American Board of Medical Genetics
 

Chapters in Books

Chehab, FF, Ewart-Toland, A, Mounzih, K, Qiu, J and Ogus, S. "Genetics and physiology link leptin to the repoductive system." In Leptin and Reproduction. Edited by M.C. Henson and V.D. Castracane. -. New York: Kluwer Academic/Plenum Publishers, January 2003.

Dworkin AM, Huang T, Ewart Toland A.. "The role of epigenetics in breast cancer: Implications for diagnosis, prognosis and treatments." In Pharmacogenetics of Breast Cancer: Towards the Individualization of Therapy.. Edited by B.L. Jones. 45-60. New York, NY, US|USA: Informa Health Care, January 2008.

Ewart Toland A.. "Mouse Models." In Encyclopedia of Cancer 2nd Edition.. Edited by M. Schwab. -. Columbus: Elsevier, January 2008.

Toland AE. "Aberrant epigenetic regulation in breast cancer." In Patho-Epigenetics of Disease. Edited by Minarovits J and Niller HH. 91-122. New York, NY, US|USA: Springer, May 2012.

Toland AE. "The role of germline genetics in colorectal cancer susceptibility and prognosis." In Colorectal Cancer Biology: From Genes to Tumor. Edited by Rajunor Ettarh. 11-36. Rijeka, HR|HRV: InTech, February 2012.

Amanda Ewart Toland. "Interaction between genetics and epigenetics in cancer." In Epigenetics and Complex Traits. Edited by Naumova AK, Greenwood CMT. 209-229. New York, NY, US|USA: Springer, September 2013.

 

Clinical Services

07/01/2005 Clinical Cancer Genetics (OSU, Internal Medicine, Division of Human Genetics)

Degrees

1990 B.A., Franklin and Marshall College

1996 Ph.D., University of Utah

 

Editorial Activities

2000 - present Human Mutation
2004 - 2010 Carcinogenesis
2006 - present Clinical Cancer Research
2006 Cancer Letters
2006 - 2008 Cancer Research
2007 - present Mammalian Genome
2007 - present PLoS One
2007 - present PLoS One
2007 - present PLoS Genetics
2007 Current Stem Cell Research & Therapy
2007 BMC Genetics
2007 - 2010 Cancer, Epidemiology, Biomarkers and Prevention
2008 - present International Journal of Cancer
2009 Neurobiology of Disease
2009 - 2012 Molecular Carcinogenesis
2010 - present Breast Cancer Research and Treatment
2010 - present Acta Obstetricia et Gynecologica Scandinavica
2010 - present National Cancer Institute PDQ Cancer Genetics Editorial Board
2010 - present Expert Review of Molecular Diagnostics
2011 - present Cancer Genetics
2011 - present Proceedings in the National Academy of Sciences
2011 - present Gut
2011 - present Future Oncology
2011 - present Epigenomics
2011 - present American Journal of Obstretrics and Gynecology
2011 - present BMC Molecular Biology
2012 - present Journal of the European Academy of Dermatology and Venereology
2012 Tumori
2012 Gastroenterology
2012 - 2014 Clinical Genetics
2013 Nature Genetics
2013 Breast Cancer Research
2013 BMC Cancer
 

Honors

1990 Phi Beta Kappa.
1999 Melvin Grumbach Award for Excellence in Research.
2002 - present Best Overall Poster. UCSF Prostate Spore Retreat.
2007 - present American Cancer Society Research Scholar. American Cancer Society.
2010 2010 NIH Merit Awardee (Group award).
2013 Excellence in Teaching. OSU College of Medicine.
 

Journal Articles

Watkins, WS, O'Connell P, Stevens J, Culver M, Ewart A, Jorde LB.. "A Bgl II RFLP near the human neurofibromatosis type 1 (NF1) gene." Nucleic Acids Research. Vol. 11, no. 23. (December 1991.): 6662-.

Ewart, AK, Morris, CA, Ensing, GJ, Loker, J, Moore, C, Leppert, M, Keating, M. "A human vascular disorder, supravalvular aortic stenosis, maps to chromosome 7.." Proceedings of the National Academy of Sciences of the United States of America. Vol. 90, no. 8. (April 1993.): 3226-3230.

Curran, ME, Atkinson, DL, Ewart, AK, Morris, CA, Leppert, MF Keating, MT. "The elastin gene is disrupted by a translocation associated with supravalvular aortic stenosis.." Cell. Vol. 73, no. 1. (April 1993.): 159-168.

Ewart, AK, Morris, CA, Atkinson, D, Jin, W, Sternes, K, Spallone, P, Stock, AD, Leppert, M, Keating, MT. "Hemizygosity at the elastin locus in a developmental disorder, Williams syndrome.." Nature genetics. Vol. 5, no. 1. (September 1993.): 11-16.

Ewart, AK, Jin, W, Atkinson, D, Morris, CA Keating, MT. "Supravalvular aortic stenosis associated with a deletion disrupting the elastin gene.." The journal of clinical investigation. Vol. 93, no. 3. (March 1994.): 1071-1077.

Lowery, MC, Morris, CA, Ewart, A, Brothman, LJ, Zhu, XL, Leonard, CO, Carey, JC, Keating, M, Brothman, AR. "Strong correlation of elastin deletions, detected by FISH, with Williams syndrome: evaluation of 235 patients.." American journal of human genetics. Vol. 57, no. 1. (July 1995.): 49-53.

Frangiskakis, JM, Ewart, AK, Morris, CA, Mervis, CB, Bertrand, J, Robinson, BF, Klein, BP, Ensing, GJ,Everett, LA, Green, ED, Proschel, C, Gutowski, NJ Noble, M, Atkinson, DL, Odelberg, SJ, Keating, MT. "LIM-kinase1 hemizygosity implicated in impaired visuospatial constructive cognition.." Cell. Vol. 86, no. 1. (July 1996.): 59-69.

Li, DY, Toland, AE, Boak, BB, Atkinson, DL, Ensing, GJ, Morris, CA, Keating, MT. "Elastin point mutations cause an obstructive vascular disease, supravalvular aortic stenosis.." Human molecular genetics. Vol. 6, no. 7. (July 1997.): 1021-1028.

Mounzih, K, Qiu, J, Ewart-Toland, A, Chehab, FF. "Leptin is not necessary for gestation and parturition but regulates maternal nutrition via a leptin resistance state.." Endocrinology. Vol. 139, no. 12. (December 1998.): 5259-5262.

Ewart-Toland, A, Enns, GM, Cox, VA, Mohan, GC, Rosenthal, P, Golabi, M. "Severe congenital anomalies requiring transplantation in children with Kabuki syndrome." American journal of medical genetics. Vol. 80, no. 4. (December 1998.): 362-367.

Ewart-Toland, A, Mounzih, K, Qiu, J, Chehab, FF. "Effect of the genetic background on the reproduction of leptin-deficient obese mice.." Endocrinology. Vol. 140, no. 2. (February 1999.): 732-738.

Ewart-Toland, A, Yankowitz, J, Winder, A, Imagire, R, Cox, VA, Aylsworth, AS, Golabi, M. "Oculoauriculovertebral abnormalities in children of diabetic mothers.." American journal of medical genetics. Vol. 90, no. 4. (February 2000.): 303-309.

Qiu, J, Ogus, S, Mounzih, K, Ewart-Toland, A, Chehab, FF. "Leptin-deficient mice backcrossed to the BALB/cJ genetic background have reduced adiposity, enhanced fertility, normal body temperature, and severe diabetes.." Endocrinology. Vol. 142, no. 8. (August 2001.): 3421-3425.

Chehab, FF, Qiu, J, Mounzih, K, Ewart-Toland, A, Ogus, S. "Leptin and reproduction.." Nutrition reviews. Vol. 60, no. 10 Pt 2. (October 2002.): S39-46.

Ewart-Toland, Amanda; Briassouli, Paraskevi; de Koning, John, P; Mao, Jian-Hua; Yuan, Jinwei; Chan, Florence; MacCarthy-Morrogh, Lucy; Ponder, Bruce A, J; Nagase, Hiroki; Burn, John; Ball, Sarah; Almeida, Maria; Linardopoulos, Spiros; Balmain, Allan. "Identification of Stk6/STK15 as a candidate low-penetrance tumor-susceptibility gene in mouse and human.." Nature genetics. Vol. 34, no. 4. (August 2003.): 403-412.

Ewart-Toland, A, Chan, J, Yuan, J, Balmain, A, and Ma, J.. "A gain of function TGFB1 polymorphism may be associated with late stage prostate cancer.." Cancer Epidemiol Biomarkers Prev. Vol. 13, no. 5. (May 2004.): 759-764.

Ewart-Toland A, Balmain, A. "The genetics of cancer susceptibility: from mouse to man.." Toxicologic pathology. Vol. 32, no. Suppl 1. (March 2004.): 26-30.

Dai, Q, Cai, Q-Y, Shu, X-O, Ewart-Toland, A, Wen, W-Q, Balmain, A, Gao, Y-T, Zheng, W. "Synergistic effects of STK15 gene polymorphisms and endogenous estrogen exposure in the risk of breast cancer.." Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. Vol. 13, no. 12. (December 2004.): 2065-2070.

Ewart-Toland, A, Dai, Q, Gao, Y-T, Nagase, H, Dunlop, MG, Farrington, SM, Barnetson, RA, Anton-Culver, H, Peel, D, Ziogas, A, Lin, D, Miao, X, Sun, T Ostrander, EA, Stanford, JL, Langlois, M, Chan, JM, Yuan, J, Harris, CC, Bowman, ED, Clayman GL, et al.. "Aurora-A/STK15 T+91A is a general low penetrance cancer susceptibility gene: a meta-analysis of multiple cancer types.." Carcinogenesis. Vol. 26, no. 8. (August 2005.): 1368-1373.

Chen, Y, Toland, AE, McLennan, J, Fridlyand, J, Crawford, B, Costello, JF, Ziegler, JL. "Lack of germ-line promoter methylation in BRCA1-negative families with familial breast cancer.." Genetic testing. Vol. 10, no. 4. (January 2006.): 281-284.

Spearman AD, Sweet K, Zhao XP, McLennan J, Couch FJ, Toland AE. "Clinically applicable models to characterize BRCA1 and BRCA2 variants of uncertain significance.." J Clin Oncol. Vol. 26, no. 33. (November 2008.): 5393-5400.

Fleming JL, Huang T H-M, Toland AE. "The role of parental and grandparental epigenetic alterations in familial cancer risk." Cancer Research. Vol. 68, no. 22. (November 2008.): 9116-9121.

Mahler KL, Fleming, JL, Dworkin, AM, Gladman, N, Cho, H-Y, Mao, J-H, Balmain A, Toland AE. "Sequence divergence of Mus Spretus and Mus Musculus across a skin cancer susceptibility locus." BMC Genomics. Vol. 23, no. 9. (December 2008.): 626-.

Toland AE, Rozek LS, Presswala, S, Rennert G, Gruber SB.. "PTPRJ haplotypes and colorectal cancer risk.." Cancer Epidemiology, Biomarkers & Prevention. Vol. 17, no. 10. (October 2008.): 2782-2785.

Dworkin AM, Tseng SY, Allain DC, Iwenofu OH, Peters SB, Toland AE.. "Merkel Cell Polyomavirus in Cutaneous Squamous Cell Carcinoma of Immunocompetent Individuals." Journal of Investigative Dermatology. Vol. 129, no. 12. (December 2009.): 2868-2874.

Dworkin AM, Spearman AD, Tseng SY, Sweet K, Toland AE. "Methylation not a frequent “second hit” in tumors with germline BRCA mutations." Familial Cancer. Vol. 8, no. 4. (April 2009.): 339-346.

Antoniou AC; Sinilnikova OM; McGuffog L; Healey S; Nevanlinna H; Heikkinen T; Simard J; Spurdle AB; Beesley J; Chen X; Neuhausen SL; Ding YC; Couch FJ; Wang X; Fredericksen Z; Peterlongo P; Peissel B; Bonanni B; Viel A; Bernard L; Radice P; Szabo CI; Foretova L; Zikan M; Claes K; Greene MH; Mai PL; Rennert G; Lejbkowicz F; Andrulis IL; Ozcelik H; Glendon G; Gerdes AM; Thomassen M; Sunde L; Caligo MA; Laitman Y; Kontorovich T; Cohen S; Kaufman B; Dagan E; Baruch RG; Friedman E; Harbst K; Barbany-Bustinza G; Rantala J; Ehrencrona H; Karlsson P; Domchek SM; Nathanson KL; Osorio A; Blanco I; Lasa A; Benítez J; Hamann U; Hogervorst FB; Rookus MA; Collee JM; Devilee P; Ligtenberg MJ; van der Luijt RB; Aalfs CM; Waisfisz Q; Wijnen J; van Roozendaal CE; Peock S; Cook M; Frost D; Oliver C; Platte R; Evans DG; Lalloo F; Eeles R; Izatt L; Davidson R; Chu C; Eccles D; Cole T; Hodgson S; Godwin AK; Stoppa-Lyonnet D; Buecher B; Léoné M; Bressac-de Paillerets B; Remenieras A; Caron O; Lenoir GM; Sevenet N; Longy M; Ferrer SF; Prieur F; Goldgar D; Miron A; John EM; Buys SS; Daly MB; Hopper JL; Terry MB; Yassin Y; Singer C; Gschwantler-Kaulich D; Staudigl C; Hansen TO; Barkardottir RB; Kirchhoff T; Pal P; Kosarin K; Offit K; Piedmonte M; Rodriguez GC; Wakeley K; Boggess JF; Basil J; Schwartz PE; Blank SV; Toland AE; Montagna M; Casella C; Imyanitov EN; Allavena A; Schmutzler RK; Versmold B; Engel C; Meindl A; Ditsch N; Arnold N; Niederacher D; Deissler H; Fiebig B; Suttner C; Schönbuchner I; Gadzicki D; Caldes T; de la Hoya M; Pooley KA; Easton DF; Chenevix-Trench G. "Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers.." Human Molecular Genetics. Vol. 18, no. 22. (November 2009.): 4442-4456.

Dworkin AM, Huang TH, Toland AE. "Epigenetic alterations in the breast: Implications for breast cancer detection, prognosis and treatment.." Seminars in Cancer Biology. Vol. 19, no. 3. (June 2009.): 165-171.

Osorio A, Milne RL, Pita G, Peterlongo P, Heikkinen T, Simard J, Chenevix-Trench G, Spurdle AB, Beesley J, Chen X, Healey S; KConFab, Neuhausen SL, Ding YC, Couch FJ, Wang X, Lindor N, Manoukian S, Barile M, Viel A, Tizzoni L, Szabo CI, Foretova L, Zikan M, Claes K, Greene MH, Mai P, Rennert G, Lejbkowicz F, Barnett-Griness O, Andrulis IL, Ozcelik H, Weerasooriya N; OCGN, Gerdes AM, Thomassen M, Cruger DG, Caligo MA, Friedman E, Kaufman B, Laitman Y, Cohen S, Kontorovich T, Gershoni-Baruch R, Dagan E, Jernström H, Askmalm MS, Arver B, Malmer B; SWE-BRCA, Domchek SM, Nathanson KL, Brunet J, Ramón Y Cajal T, Yannoukakos D, Hamann U; HEBON, Hogervorst FB, Verhoef S, García EG, Wijnen JT, van den Ouweland A; EMBRACE, Easton DF, Peock S, Cook M, Oliver CT, Frost D, Luccarini C, Evans DG, Lalloo F, Eeles R, Pichert G, Cook J, Hodgson S, Morrison PJ, Douglas F, Godwin AK; GEMO, Sinilnikova OM, Barjhoux L, Stoppa-Lyonnet D, Moncoutier V, Giraud S, Cassini C, Olivier-Faivre L, Révillion F, Peyrat JP, Muller D, Fricker JP, Lynch HT, John EM, Buys S, Daly M, Hopper JL, Terry MB, Miron A, Yassin Y, Goldgar D; Breast Cancer Family Registry, Singer CF, Gschwantler-Kaulich D, Pfeiler G, Spiess AC, Hansen TV, Johannsson OT, Kirchhoff T, Offit K, Kosarin K, Piedmonte M, Rodriguez GC, Wakeley K, Boggess JF, Basil J, Schwartz PE, Blank SV, Toland AE, Montagna M, Casella C, Imyanitov EN, Allavena A, Schmutzler RK, Versmold B, Engel C, Meindl A, Ditsch N, Arnold N, Niederacher D, Deißler H, Fiebig B, Varon-Mateeva R, Schaefer D, Froster UG, Caldes T, de la Hoya M, McGuffog L, Antoniou AC, Nevanlinna H, Radice P, Benítez J.. "Evaluation of a candidate breast cancer associated SNP in ERCC4 as a risk modifier in BRCA1 and BRCA2 mutation carriers. Results from the Consortium of Investigators of Modifiers of BRCA1/BRCA2 (CIMBA).." Br J Cancer. Vol. 101, no. 12. (November 2009.): 2048-2051.

Dworkin AM, Tober KL, Duncan FJ, Yu L, VanBuskirk AM, Oberyszyn TM, Toland AE. "Chromosomal aberrations in UVB-induced tumors in immunosuppressed mice." Genes, Chromosomes, Cancer. Vol. 48, no. 6. (June 2009.): 490-501.

Sweet K, Senter L, Pilarski R, Wei L, Toland AE.. "Characterization of BRCA1 ring finger variants of uncertain significance." Breast Cancer Res Treat. Vol. 119, no. 3. (January 2010.): 737-743.

Antoniou AC, Beesley J, McGuffog L, Sinilnikova OM, Healey S, Neuhausen SL, Ding YC, Rebbeck TR, Weitzel JN, Lynch HT, Isaacs C, Ganz PA, Tomlinson G, Olopade OI, Couch FJ, Wang X, Lindor NM, Pankratz VS, Radice P, Manoukian S, Peissel B, Zaffaroni D, Barile M, Viel A, Allavena A, Dall'Olio V, Peterlongo P, Szabo CI, Zikan M, Claes K, Poppe B, Foretova L, Mai PL, Greene MH, Rennert G, Lejbkowicz F, Glendon G, Ozcelik H, Andrulis IL; Ontario Cancer Genetics Network, Thomassen M, Gerdes AM, Sunde L, Cruger D, Birk Jensen U, Caligo M, Friedman E, Kaufman B, Laitman Y, Milgrom R, Dubrovsky M, Cohen S, Borg A, Jernström H, Lindblom A, Rantala J, Stenmark-Askmalm M, Melin B; SWE-BRCA, Nathanson K, Domchek S, Jakubowska A, Lubinski J, Huzarski T, Osorio A, Lasa A, Durán M, Tejada MI, Godino J, Benitez J, Hamann U, Kriege M, Hoogerbrugge N, van der Luijt RB, van Asperen CJ, Devilee P, Meijers-Heijboer EJ, Blok MJ, Aalfs CM, Hogervorst F, Rookus M; HEBON, Cook M, Oliver C, Frost D, Conroy D, Evans DG, Lalloo F, Pichert G, Davidson R, Cole T, Cook J, Paterson J, Hodgson S, Morrison PJ, Porteous ME, Walker L, Kennedy MJ, Dorkins H, Peock S; EMBRACE, Godwin AK, Stoppa-Lyonnet D, de Pauw A, Mazoyer S, Bonadona V, Lasset C, Dreyfus H, Leroux D, Hardouin A, Berthet P, Faivre L; GEMO, Loustalot C, Noguchi T, Sobol H, Rouleau E, Nogues C, Frénay M, Vénat-Bouvet L; GEMO, Hopper JL, Daly MB, Terry MB, John EM, Buys SS, Yassin Y, Miron A, Goldgar D; Breast Cancer Family Registry, Singer CF, Dressler AC, Gschwantler-Kaulich D, Pfeiler G, Hansen TV, Jønson L, Agnarsson BA, Kirchhoff T, Offit K, Devlin V, Dutra-Clarke A, Piedmonte M, Rodriguez GC, Toland AE [39 authors]. "Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutations carriers: implications for risk prediction." Cancer Research. Vol. 70, no. 23. (December 2010.): 9742-9754.

Ransburgh DJR, Chiba N, Ishioka C, Toland AE, Parvin JD. "Identification of breast tumor mutations in BRCA1 that abolish its function in homologous DNA recombination." Cancer Research. Vol. 70, no. 3. (February 2010.): 988-995.

Gaudet MM, Kirchhoff T, Green T, Joseph J, Korn J, Guiducci C, Segre A, McGee K, McGuffog L, Kartsonaki C, Morrison J, Sinilnikova OM, Stoppa-Lyonnet D, Hogervorst FBL, Greene M, Caldes T, Nevanlinna H, Lazaro C, Barkardottir R, Devilee P, Olopade F, Neuhausen SL, Wang X, Fredericksen Z, Radice P, Narod S, Phelan C, Rennert G, Andrulis I, Toland AE, Montagna M, Friedman E, Borg A, Beattie M, Ramus S, Domchek SM, Nathanson KL, Spurdle A, Healey S, John EM, Hopper JL, Buys SS, Daly MB, Southey M, Terry M-B, Tung N, Hansen TVO, Osorio A, Weitzel J, Garber J, Hamann U, Peock S, Godwin AK, Wappenschmidt, B, Dean M, Gold B, Klein R, Couch FJ, Chenevix-Trench G, Easton DF, Daly M, Antoniou AC, Altshuler D, Offit K.. "Common variants and modification of penetrance of BRCA2-associated breast cancer." PLoS Genetics. Vol. 6, no. 10. (October 2010.): e1001183-.

Antoniou AC, Wang X, Fredericksen ZS, McGuffog L, Tarrell R, Morrison J, Kartsonaki C, Lesnick T, Ghoussaini M, Barrowdale D, Peock S, Sinilnikova OM, Stoppa-Lyonnet D, Hogervorst FBL, Devilee P, Lubinski J, Jakubowska A, Spurdle A, Healey S, John EM, Hopper JL, Buys SS, Daly MB, Southey S, Terry M-B, Schmutzler RK, Domchek SM, Nathanson KL, Greene M, Friedman E, Andrulis I, Offit K, Borg A, Harbst K, Gerdes A-M, Thomassen M, Peterlongo P, Radice P, Caldes T, Singer CF, Greene MH, Guidugli L, Lindor NM, Hansen TVO, Lindblom A, Rantala J, Guillermo IB, Lazaro C, Garber J, Ramus S, Gayther S, Phelan C, Narod S, Szabo CI, Osorio A, Caligo MA, Beattie M, Hamann U, Godwin AK, Montagna M, Pasini B, Neuhausen SL, Karlan BY, Tung N, Nevanlinna H, Toland AE, Weitzel J, Olopade F, Rubinstein W, Martin NG, Montgomery GW, Chang-Claude J, Brauch H, Severi G , Cox A, Miron P, Eccles D, Eckel-Passow J, Vachon C, Dunning A, Pharoah PPD, Pankratz VS, Hakonarson H, Chenevix-Trench G, Easton DF, Couch FJ.. "A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor-negative breast cancer in the general population." Nature Genetics. Vol. 42, no. 10. (October 2010.): 885-892.

Dworkin AM, Ridd K, Bautista D, Allain DC, Iwenofu OH, Roy R, Bastian BC, Toland AE. "Germline variation controls the architecture of somatic alterations in tumors." PLoS Genetics. Vol. 6, no. 9. (September 2010.): e1001136-.

Mavaddat N, Barrowdale D, AndrulisIL, Domchek SM, Eccle D, Nevanlinna H, Ramus SJ, Spurdle A, Robson M, Sherman M, Mulligan AM, Couch FJ, Engel C, McGuffog L, Healey S, Sinilnikova OM, Southey MC, Terry MB, Goldgar D, O’Malley F, John EM, Janavicius R, Tihomirova L, O Hansen TV, Nielsen FC, Osorio A, Stavropoulou A, Benítez J, Manoukian S, Peissel B, Barile M, Volorio S, Pasini B, Dolcetti R, Putignano AL, Ottini L, Radice P, Hamann U, Rashid MU, Hogervorst FB, Kriege M, van der Luijt RB, HEBON, EMBRACE1, Peock S, Frost S, Evans DG, Brewer C, Walker L, Rogers MT, Side LE, Houghton C, Weaver J, Godwin AK, Schmutzler RK, Wappenschmidt B, Meindl A, Kast K, Arnold N, Niederacher D, Sutter C, Deissler H, Gadzicki D, Preisler-Adams S, Varon-Mateeva R, Schönbuchner I, Gevensleben H, GEMO Study Collaborators, Stoppa-Lyonnet D, Belotti M, Barjhoux L, Isaacs C, Peshkin BN, Caldes T, de al Hoya M, Cañadas C, Heikkinen T, Heikkilä P, Aittomäki K, Blanco I, Lazaro C, Brunet J, Agnarsson BA, Arason A, Barkardottir RB, Dumont M, Simard J, Montagna M, Agata S, D’Andrea E, Yan M, Fox S, kConFab Investigators, Rebbeck TR Rubinstein W, Tung N, Garber JE, Wang X, Fredericksen Z, Pankratz VS, Lindor NM, Szabo C, Offit K, Sakr R, Gaudet MM, Singer CF, Tea MK, Rappaport C, Mai PL, Greene MH, Sokolenko A, Imyanitov E, Toland AE, Senter L, Sweet K, Thomassen M, Gerdes AM, Kruse T, Caligo M, Aretini P, Rantala J, von Wachenfeld A, Henriksson K, SWE-BRCA Collaborators, Steele L, Neuhausen SL, Nussbaum B, Beattie M, Odunsi K, Sucheston L, Gayther SA, Nathanson K, Gross J, Walsh C, Karlan B, Chenevix-Trench G, Easton DF, Antoniou AC on behalf of the Consortium of Investigators of Modifiers of BRCA1. "Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA)." Cancer Epidemiology, Biomarkers and Prevention. Vol. 21, no. 1. (December 2011.): 134-147.

Antoniou AC, Kartsonaki C, Sinilnikova OM, Soucy P, McGuffog L, Healey S, Lee A, Peterlongo P, Manoukian S, Peissel B, Zaffaroni D, Cattaneo E, Barile M, Pensotti V, Pasini B, Dolcetti R, Giannini G, Putignano AL, Varesco L, Radice P, Mai PL, Greene MH, Andrulis IL, Glendon G, Ozcelik H; Ontario Cancer Genetics Network, Thomassen M, Gerdes AM, Kruse TA, Jensen UB, Crüger DG, Caligo MA, Laitman Y, Milgrom R, Kaufman B, Paluch-Shimon S, Friedman E, Loman N, Harbst K, Lindblom A, Arver B, Ehrencrona H, Melin B; SWE-BRCA, Nathanson KL, Domchek SM, Rebbeck T, Jakubowska A, Lubinski J, Gronwald J, Huzarski T, Byrski T, Cybulski C, Gorski B, Osorio A, Cajal TR, Fostira F, Andrés R, Benitez J, Hamann U, Hogervorst FB, Rookus MA, Hooning MJ, Nelen MR, van der Luijt RB, van Os TA, van Asperen CJ, Devilee P, Meijers-Heijboer HE, Gómez Garcia EB; HEBON, Peock S, Cook M, Frost D, Platte R, Leyland J, Evans DG, Lalloo F, Eeles R, Izatt L, Adlard J, Davidson R, Eccles D, Ong KR, Cook J, Douglas F, Paterson J, Kennedy MJ, Miedzybrodzka Z; EMBRACE, Godwin A, Stoppa-Lyonnet D, Buecher B, Belotti M, Tirapo C, Mazoyer S, Barjhoux L, Lasset C, Leroux D, Faivre L, Bronner M, Prieur F, Nogues C, Rouleau E, Pujol P, Coupier I, Frénay M; GEMO Study Collaborators, Hopper JL, Daly MB, Terry MB, John EM, Buys SS, Yassin Y, Miron A, Goldgar D; Breast Cancer Family Registry, Singer CF, Tea MK, Pfeiler G, Dressler AC, Hansen TV, Jønson L, Ejlertsen B, Barkardottir RB, Kirchhoff T, Offit K, Piedmonte M, Rodriguez G, Small L, Boggess J, Blank S, Basil J, Azodi M, Toland AE, Montagna M, Tognazzo S, Agata S, Imyanitov E, Janavicius R, Lazaro C, Blanco I, Pharoah PD, Sucheston L, Karlan BY, Walsh CS, Olah. "Common alleles at 6q25.1 and 1p11.2 are associated with breast cancer risk for BRCA1 and BRCA2 mutation carriers.." Human Molecular Genetics. Vol. 20, no. 16. (August 2011.): 3304-3321.

Cox DG, Simard J, Sinnett D, Hamdi Y, Soucy P, Ouimet M, Barjhoux L, Verny-Pierre C, McGuffog L, Healey S, Szabo C, Greene MH, Mai PL, Andrulis IL; Ontario Cancer Genetics Network, Thomassen M, Gerdes AM, Caligo MA, Friedman E, Laitman Y, Kaufman B, Paluch SS, Borg A, Karlsson P, Askmalm MS, Bustinza GB; SWE-BRCA collaborators, Nathanson K, Domchek SM, Rebbeck TR, Benítez J, Hamann U, Rookus MA, van den Ouweland AM, Ausems MG, Aalfs CM, van Asperen CJ, Devilee P, Gille HJ; HEBON; EMBRACE, Peock S, Frost D, Evans DG, Eeles R, Izatt L, Adlard J, Paterson J, Eason J, Godwin AK, Remon MA, Moncoutier V, Gauthier-Villars M, Lasset C, Giraud S, Hardouin A, Berthet P, Sobol H, Eisinger F, Paillerets BB, Caron O, Delnatte C; GEMO Study Collaborators, Goldgar D, Miron A, Ozcelik H, Buys S, Southey MC, Terry MB; the Breast Cancer Family Registry, Singer CF, Dressler AC, Tea MK, Hansen TV, Johannsson O, Piedmonte M, Rodriguez GC, Basil JB, Blank S, Toland AE, Montagna M, Isaacs C, Blanco I, Gayther SA, Moysich KB, Schmutzler RK, Wappenschmidt B, Engel C, Meindl A, Ditsch N, Arnold N, Niederacher D, Sutter C, Gadzicki D, Fiebig B, Caldes T, Laframboise R, Nevanlinna H, Chen X, Beesley J, Spurdle AB, Neuhausen SL, Ding YC, Couch FJ, Wang X, Peterlongo P, Manoukian S, Bernard L, Radice P, Easton DF, Chenevix-Trench G, Antoniou AC, Stoppa-Lyonnet D, Mazoyer S, Sinilnikova OM;. "Common variants of the BRCA1 wild-type allele modify the risk of breast cancer in BRCA1 mutation carriers." Human Molecular Genetics. Vol. 20, no. 23. (December 2011.): 4732-4747.

Im KM, Kirchhoff T, Wang X, Green T, Chow CY, Vijai J, Korn J, Gaudet MM, Fredericksen Z, Shane Pankratz V, Guiducci C, Crenshaw A, McGuffog L, Kartsonaki C, Morrison J, Healey S, Sinilnikova OM, Mai PL, Greene MH, Piedmonte M, Rubinstein WS; HEBON, Hogervorst FB, Rookus MA, Collée JM, Hoogerbrugge N, van Asperen CJ, Meijers-Heijboer HE, Van Roozendaal CE, Caldes T, Perez-Segura P, Jakubowska A, Lubinski J, Huzarski T, Blecharz P, Nevanlinna H, Aittomäki K, Lazaro C, Blanco I, Barkardottir RB, Montagna M, D'Andrea E; kConFab, Devilee P, Olopade OI, Neuhausen SL, Peissel B, Bonanni B, Peterlongo P, Singer CF, Rennert G, Lejbkowicz F, Andrulis IL, Glendon G, Ozcelik H; Ontario Cancer Genetics Network, Toland AE, Caligo MA; SWE-BRCA, Beattie MS, Chan S; UKFOCR, Domchek SM, Nathanson KL, Rebbeck TR, Phelan C, Narod S, John EM, Hopper JL, Buys SS, Daly MB, Southey MC, Terry MB, Tung N, Hansen TV, Osorio A, Benitez J, Durán M, Weitzel JN, Garber J, Hamann U; EMBRACE, Peock S, Cook M, Oliver CT, Frost D, Platte R, Evans DG, Eeles R, Izatt L, Paterson J, Brewer C, Hodgson S, Morrison PJ, Porteous M, Walker L, Rogers MT, Side LE, Godwin AK, Schmutzler RK, Wappenschmidt B, Laitman Y, Meindl A, Deissler H, Varon-Mateeva R, Preisler-Adams S, Kast K, Venat-Bouvet L, Stoppa-Lyonnet D, Chenevix-Trench G, Easton DF, Klein RJ, Daly MJ, Friedman E, Dean M, Clark AG, Altshuler DM, Antoniou AC, Couch FJ, Offit K, Gold B.. "Haplotype structure in Ashkenazi Jewish BRCA1 and BRCA2 mutation carriers." Human Genetics. Vol. 130, no. 5. (May 2011.): 685-699.

Efird JT, Toland AE, Lea CS, Phillips CJ. "The combined influence of oral contraceptives and human papillomavirus on cutaneous squamous cell carcinoma." Clin Med Insights Oncol. Vol. 5, (March 2011.): 55-75.

Mulligan AM, Couch FJ, Barrowdale D, Domchek SM, Eccles D, Nevanlinna H, Ramus SJ, Robson M, Sherman M, Spurdle AB, Wappenschmidt B, Lee A, McGuffog L, Healey S, Sinilnikova OM, Janavicius R, Hansen TV, Nielsen FC, Ejlertsen B, Osorio A, Munoz-Repeto I, Duran M, Godino J, Pertesi M, Benitez J, Peterlongo P, Manoukian S, Peissel B, Zaffaroni D, Cattaneo E, Bonanni B, Viel A, Pasini B, Papi L, Ottini L, Savarese A, Bernard L, Radice P, Hamann U, Verheus M, Meijers-Heijboer HE, Wijnen J, Gomez Garcia EB, Nelen MR, Kets CM, Seynaeve C, Tilanus-Linthorst MM, van der Luijt RB, van Os T, Rookus M, Frost D, Jones JL, Evans DG, Lalloo F, Eeles R, Izatt L, Adlard J, Davidson R, Cook J, Donaldson A, Dorkins H, Gregory H, Eason J, Houghton C, Barwell J, Side LE, McCann E, Murray A, Peock S, Godwin A, Schmutzler RK, Rhiem K, Engel C, Meindl A, Ruehl I, Arnold N, Niederacher D, Sutter C, Deissler H, Gadzicki D, Kast K, Preisler-Adams S, Varon-Mateeva R, Schoenbuchner I, Fiebig B, Heinritz W, Schafer D, Gevensleben H, Caux-Moncoutier V, Fassy-Colcombet M, Cornelis F, Mazoyer S, Leone M, Boutry-Kryza N, Hardouin A, Berthet P, Muller D, Fricker JP, Mortemousque I, Pujol P, Coupier I, Lebrun M, Kientz C, Longy M, Sevenet N, Stoppa-Lyonnet D, Isaacs C, Caldes T, de Al Hoya M, Heikkinen T, Aittomaki K, Blanco I, Lazaro C, Barkardottir RB, Soucy P, Dumont M, Simard J, Montagna M, Tognazzo S, D'Andrea E, Fox S, Yan M, Rebbeck TR, Olopade OI, Weitzel JN, Lynch HT, Ganz PA, Tomlinson GE, Wang X, Fredericksen Z, Pankratz VS, Lindor NM, Szabo C, Offit K, Sakr R, Gaudet M, Bhatia J, Kauff N, Singer CF, Tea MK, Gschwantler-Kaulich D, Fink-Retter A, Mai PL, Greene MH, Imyanitov E, O'Malley FP, Ozceli. "Common breast cancer susceptibility alleles are associated with tumor subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2." Breast Cancer Research. Vol. 13, no. 6. (November 2011.): R110-.

Fleming JL, Phiel CJ, Toland AE. "The role for oxidative stress in aberrant DNA methylation in Alzheimer's disease." Current Alzheimer Research. Vol. 9, no. 9. (November 2012.): 1077-1096.

Bolton KL, Chenevix-Trench G, Goh C, Sadetzki S, Ramus SJ, Karlan BY, Lambrechts D, Despierre E, Barrowdale D, McGuffog L, Healey S, Easton DF, Sinilnikova O, Benítez J, García MJ, Neuhausen S, Gail MH, Hartge P, Peock S, Frost D, Evans DG, Eeles R, Godwin AK, Daly MB, Kwong A, Ma ES, Lázaro C, Blanco I, Montagna M, D'Andrea E, Nicoletto MO, Johnatty SE, Kjær SK, Jensen A, Høgdall E, Goode EL, Fridley BL, Loud JT, Greene MH, Mai PL, Chetrit A, Lubin F, Hirsh-Yechezkel G, Glendon G, Andrulis IL, Toland AE, Senter L, Gore ME, Gourley C, Michie CO, Song H, Tyrer J, Whittemore AS, McGuire V, Sieh W, Kristoffersson U, Olsson H, Borg Å, Levine DA, Steele L, Beattie MS, Chan S, Nussbaum RL, Moysich KB, Gross J, Cass I, Walsh C, Li AJ, Leuchter R, Gordon O, Garcia-Closas M, Gayther SA, Chanock SJ, Antoniou AC, Pharoah PD; EMBRACE; kConFab Investigators; Cancer Genome Atlas Research Network.. "Association between BRCA1 and BRCA2 mutations and survival in women with invasive epithelial ovarian cancer." JAMA. Vol. 307, no. 4. (January 2012.): 382-390.

Ding YC, McGuffog L, Healey S, Friedman E, Laitman Y, Shimon-Paluch S, Kaufman B, Liljegren A, Lindblom A, Olsson H, Kristoffersson U, Stenmark Askmalm M, Melin B, Domchek SM, Nathanson KL, Rebbeck TR, Jakubowska A, Lubinski J, Jaworska K, Durda K, Gronwald J, Huzarski T, Cybulski C, Byrski T, Osorio A, Ramony Cajal T, Stavropoulou AV, Benítez J, Hamann U, Rookus MA, Aalfs CM, de Lange J, Meijers-Heijboer HE, Oosterwijk JC, van Asperen CJ, Gomez-Garcia EB, Hoogerbrugge N, Jager A, van der Luijt RB, Easton DF, Peock S, Frost D, Ellis SD, Platte R, Fineberg E, Evans DG, Lalloo F, Izatt L, Eeles RA, Adlard J, Davidson R, Eccles DM, Cole T, Cook J, Brewer C, Tischkowitz M, Godwin AK, Pathak HB, Stoppa-Lyonnet D, Sinilnikova OM, Mazoyer S, Barjhoux L, Leone M, Gauthier-Villars M, Caux-Moncoutier V, de Pauw A, Hardouin A, Berthet P, Dreyfus H, Fert Ferrer S, Collonge-Rame MA, Sokolowska J, Buys SS, Daly MB, Miron A, Terry MB, Chung WK, John EM, Southey MC, Goldgar DE, Singer CF, Tea Maria MK, Gschwantler-Kaulich D, Fink-Retter A, Hansen TV, Ejlertsen B, Johannsson OT, Offit K, Sarrel K, Gaudet MM, Vijai J, Robson ME, Piedmonte M, Andrews L, Cohn DE, Demars LR, Disilvestro P, Rodriguez GC, Toland AE, Montagna M, Agata S, Imyanitov EN, Isaacs C, Janavicius R, Lazaro C, Blanco I, Ramus SJ, Sucheston LE, Karlan BY, Gross J, Ganz PA, Beattie MS, Schmutzler RK, Wappenschmidt B, Meindl A, Arnold N, Niederacher D, Preisler-Adams S, Gadzicki D, Varon-Mateeva R, Deissler H, Gehrig A, Sutter C, Kast K, Nevanlinna H, Aittomäki K, Simard J, Spurdle AB, Beesley J, Chen X, Tomlinson GE, Weitzel JN, Garber JE, Olopade FI, Rubinstein WS, Tung N, Blum JL, Narod SA, Brummel S, Gillen DL, Lindor NM, Fredericksen Z, Pankratz VS, Couch FJ, Radice P, Peterlongo P, Greene MH, Loud JT, Mai PL, Andrulis IL, Glendon G, Ozcelik H, Gerdes AM, Thomassen M, Jensen UB, Skytte AB, Caligo MA, Lee A, Chenevix-Trench G, Antoniou AC, Neuhausen SL. "A non-synonymous polymorphism in IRS1 modifies risk of developing breast and ovariant cancers in BRCA1 and ovarian cancer in BRCA2 mutation carriers." Cancer Epidemiol Biomarkers Prev. Vol. 21, no. 8. (August 2012.): 1362-1370.

Antoniou AC, Kuchenbaecker KB, Soucy P, Beesley J, Chen X, McGuffog L, Lee A, Barrowdale D, Healey S, Sinilnikova OM, Caligo MA, Loman N, Harbst K, Lindblom A, Arver B, Rosenquist R, Karlsson P, Nathanson K, Domchek S, Rebbeck T, Jakubowska A, Lubinski J, Jaworska K, Durda K, Złowowcka-Perłowska E, Osorio A, Durán M, Andrés R, Benítez J, Hamann U, Hogervorst FB, van Os TA, Verhoef S, Meijers-Heijboer HE, Wijnen J, Gómez Garcia EB, Ligtenberg MJ, Kriege M, Collée JM, Ausems MG, Oosterwijk JC, Peock S, Frost D, Ellis SD, Platte R, Fineberg E, Evans DG, Lalloo F, Jacobs C, Eeles R, Adlard J, Davidson R, Cole T, Cook J, Paterson J, Douglas F, Brewer C, Hodgson S, Morrison PJ, Walker L, Rogers MT, Donaldson A, Dorkins H, Godwin AK, Bove B, Stoppa-Lyonnet D, Houdayer C, Buecher B, de Pauw A, Mazoyer S, Calender A, Léoné M, Bressac-de Paillerets B, Caron O, Sobol H, Frenay M, Prieur F, Ferrer SF, Mortemousque I, Buys S, Daly M, Miron A, Terry MB, Hopper JL, John EM, Southey M, Goldgar D, Singer CF, Fink-Retter A, Tea MK, Kaulich DG, Hansen TV, Nielsen FC, Barkardottir RB, Gaudet M, Kirchhoff T, Joseph V, Dutra-Clarke A, Offit K, Piedmonte M, Kirk J, Cohn D, Hurteau J, Byron J, Fiorica J, Toland AE, Montagna M, Oliani C, Imyanitov E, Isaacs C, Tihomirova L, Blanco I, Lazaro C, Teulé A, Valle JD, Gayther SA, Odunsi K, Gross J, Karlan BY, Olah E, Teo SH, Ganz PA, Beattie MS, Dorfling CM, van Rensburg EJ, Diez O, Kwong A, Schmutzler RK, Wappenschmidt B, Engel C, Meindl A, Ditsch N, Arnold N, Heidemann S, Niederacher D, Preisler-Adams S, Gadzicki D, Varon-Mateeva R, Deissler H, Gehrig A, Sutter C, Kast K, Fiebig B, Schäfer D, Caldes T, de la Hoya M, Nevanlinna H, Muranen TA, Lespérance B, Spurdle AB, Neuhausen SL, Ding YC, Wang X, Fredericksen Z, Pankratz VS, Lindor NM, Peterlongo P, Manoukian S, Peissel B, Zaffaroni D, Bonanni B, Bernard L, Dolcetti R, Papi L, Ottini L, Radice P, Greene MH, Loud JT, Andrulis IL, Ozcelik H, Mulligan AM, Glendon G, Thomassen M, Gerdes AM, Jense. "Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2 mutation carriers." Breast Cancer Res. Vol. 14, no. 1. (February 2012.): R33-.

Ramus SJ, Antoniou AC, Kuchenbaecker KB, Soucy P, Beesley J, Chen X, McGuffog L, Sinilnikova OM, Healey S, Barrowdale D, Lee A, Thomassen M, Gerdes AM, Kruse TA, Jensen UB, Skytte AB, Caligo MA, Liljegren A, Lindblom A, Olsson H, Kristoffersson U, Stenmark-Askmalm M, Melin B; SWE-BRCA, Domchek SM, Nathanson KL, Rebbeck TR, Jakubowska A, Lubinski J, Jaworska K, Durda K, Zlowocka E, Gronwald J, Huzarski T, Byrski T, Cybulski C, Toloczko-Grabarek A, Osorio A, Benitez J, Duran M, Tejada MI, Hamann U, Rookus M, van Leeuwen FE, Aalfs CM, Meijers-Heijboer HE, van Asperen CJ, van Roozendaal KE, Hoogerbrugge N, Margriet Collée J, Kriege M, van der Luijt RB; HEBON; EMBRACE, Peock S, Frost D, Ellis SD, Platte R, Fineberg E, Evans DG, Lalloo F, Jacobs C, Eeles R, Adlard J, Davidson R, Eccles D, Cole T, Cook J, Paterson J, Douglas F, Brewer C, Hodgson S, Morrison PJ, Walker L, Porteous ME, Kennedy MJ, Pathak H, Godwin AK, Stoppa-Lyonnet D, Caux-Moncoutier V, de Pauw A, Gauthier-Villars M, Mazoyer S, Léoné M, Calender A, Lasset C, Bonadona V, Hardouin A, Berthet P, Bignon YJ, Uhrhammer N, Faivre L, Loustalot C; GEMO, Buys S, Daly M, Miron A, Beth Terry M, Chung W, John EM, Southey M, Goldgar D, Singer CF, Tea Maria MK, Pfeiler G, Fink-Retter A, Hansen TV, Ejlertsen B, Johannsson OT, Offit K, Kirchhoff T, Gaudet MM, Vijai J, Robson M, Piedmonte M, Phillips KA, Van Le L, Hoffman JS, Toland AE, Montagna M, Tognazzo S, Imyanitov E, Isaacs C, Janavicius R, Lazaro C, Blanco I, Tornero E, Navarro M, Moysich KB, Karlan BY, Gross J, Olah E, Vaszko T, Teo SH, Ganz PA, Beattie MS, Dorfling CM, van Rensburg EJ, Diez O, Kwong A, Schmutzler RK, Wappenschmidt B, Engel C, Meindl A, Ditsch N, Arnold N,. "Ovarian cancer susceptibility alleles and risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers." Human Mutation. Vol. 33, no. 4. (April 2012.): 690-702.

Spurdle AB, Whiley PJ, Thompson B, Feng B, Healey S, Brown MA, Pettigrew C; kConFab, Van Asperen CJ, Ausems MG, Kattentidt-Mouravieva AA, van den Ouweland AM, Belgium Uv Consortium D, Lindblom A, Pigg MH, Schmutzler RK, Engel C, Meindl A; German Consortium of Hereditary Breast and Ovarian Cancer, Caputo S, Sinilnikova OM, Lidereau R; French COVAR group collaborators, Couch FJ, Guidugli L, Hansen TV, Thomassen M, Eccles DM, Tucker K, Benitez J, Domchek SM, Toland AE, Van Rensburg EJ, Wappenschmidt B, Borg A, Vreeswijk MP, Goldgar DE; on behalf of the ENIGMA Consortium. "BRCA1 R1699Q variant displaying ambiguous functional abrogration confers immediate breast and ovarian cancer risk." J Med Genet. Vol. 49, (August 2012.): 525-532.

Towler WI, Zhang J, Ransburgh DJ, Toland AE, Ishioka C, Chiba N, Parvin JD. "Analysis of BRCA1 variants in double strand break repair by homologous recombination and single strand annealing." Human Mutation. Vol. E-pub, (November 2012.): E-pub.

Gerber MM, Hampel H, Schulz NP, Fernandez S, Wei L, Zhou XP, de la Chapelle A, Toland AE.. "Evaluation of allele-specific somatic changes of genome-wide association study susceptibility alleles in human colorectal cancers.." PLoS One. Vol. 7, no. 5. (May 2012.): e37672-.

Efird JT, Lea Suzanne, Toland A, Phillips CJ. "Informational Odds Ratio: A Useful Measure of Epidemiologic Association in Environment Exposure Studies." Environmental Health Insights. Vol. 6, (April 2012.): 17-25.

Couch FJ, Gaudet MM, Antoniou AC, Ramus SJ, Kuchenbaecker KB, Soucy P, Beesley J, Chen X, Wang X, Kirchhoff T, McGuffog L, Barrowdale D, Lee A, Healey S, Sinilnikova OM, Andrulis IL; for OCGN, Ozcelik H, Mulligan AM, Thomassen M, Gerdes AM, Jensen UB, Skytte AB, Kruse TA, Caligo MA, von Wachenfeldt A, Barbany-Bustinza G, Loman N, Soller M, Ehrencrona H, Karlsson P; for SWE-BRCA, Nathanson KL, Rebbeck TR, Domchek SM, Jakubowska A, Lubinski J, Jaworska K, Durda K, Zlowocka E, Huzarski T, Byrski T, Gronwald J, Cybulski C, Górski B, Osorio A, Durán M, Tejada MI, Benitez J, Hamann U, Hogervorst FB; for HEBON, van Os TA, van Leeuwen FE, Meijers-Heijboer HE, Wijnen J, Blok MJ, Kets M, Hooning MJ, Oldenburg RA, Ausems MG, Peock S, Frost D, Ellis SD, Platte R, Fineberg E, Evans DG, Jacobs C, Eeles RA, Adlard J, Davidson R, Eccles DM, Cole T, Cook J, Paterson J, Brewer C, Douglas F, Hodgson SV, Morrison PJ, Walker L, Porteous ME, Kennedy MJ, Side LE; for EMBRACE, Bove B, Godwin AK, Stoppa-Lyonnet D; for GEMO Study Collaborators, Fassy-Colcombet M, Castera L, Cornelis F, Mazoyer S, Léoné M, Boutry-Kryza N, Bressac-de Paillerets B, Caron O, Pujol P, Coupier I, Delnatte C, Akloul L, Lynch HT, Snyder CL, Buys SS, Daly MB, Terry M, Chung WK, John EM, Miron A, Southey MC, Hopper JL, Goldgar DE, Singer CF, Rappaport C, Tea MK, Fink-Retter A, Hansen TV, Nielsen FC, Arason A, Vijai J, Shah S, Sarrel K, Robson ME, Piedmonte M, Phillips K, Basil J, Rubinstein WS, Boggess J, Wakeley K, Ewart-Toland A, Montagna M, Agata S, Imyanitov EN, Isaacs C, Janavicius R, Lazaro C, Blanco I, Feliubadalo L, Brunet J, Gayther SA, Pharoah PP, Odunsi KO, Karlan BY, Walsh CS, Olah E, Teo SH, Ganz PA, Beattie MS, van Rensburg EJ, Dorfling CM, Diez O, Kwong A, Schmutzler RK, Wappenschmidt B, Engel C, Meindl A, Ditsch N, Arnold N, Heidemann S, Niederacher D, Preisler-Adams S, Gadzicki D, Varon-Mateeva R, Deissler H, Gehrig A, Sutter C, Kast K, Fiebig B, Heinritz W, Caldes T, de la Hoya M, Muranen TA, Ne. "Common variants at the 19p13.1 and ZNF365 loci are associated with ER subtypes of breast cancer and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers.." Cancer Epidemiol Biomarkers Prev. Vol. 21, no. 4. (April 2012.): 645-657.

Michailidou K, Hall P, Gonzalez-Neira A, Ghoussaini M, Dennis J, Milne RL, Schmidt MK, Chang-Claude J, Bojesen SE, Bolla MK, Wang Q, Dicks E, Lee A, Turnbull C, Rahman N; Breast and Ovarian Cancer Susceptibility Collaboration, Fletcher O, Peto J, Gibson L, Dos Santos Silva I, Nevanlinna H, Muranen TA, Aittomäki K, Blomqvist C, Czene K, Irwanto A, Liu J, Waisfisz Q, Meijers-Heijboer H, Adank M; Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), van der Luijt RB, Hein R, Dahmen N, Beckman L, Meindl A, Schmutzler RK, Müller-Myhsok B, Lichtner P, Hopper JL, Southey MC, Makalic E, Schmidt DF, Uitterlinden AG, Hofman A, Hunter DJ, Chanock SJ, Vincent D, Bacot F, Tessier DC, Canisius S, Wessels LF, Haiman CA, Shah M, Luben R, Brown J, Luccarini C, Schoof N, Humphreys K, Li J, Nordestgaard BG, Nielsen SF, Flyger H, Couch FJ, Wang X, Vachon C, Stevens KN, Lambrechts D, Moisse M, Paridaens R, Christiaens MR, Rudolph A, Nickels S, Flesch-Janys D, Johnson N, Aitken Z, Aaltonen K, Heikkinen T, Broeks A, Veer LJ, van der Schoot CE, Guénel P, Truong T, Laurent-Puig P, Menegaux F, Marme F, Schneeweiss A, Sohn C, Burwinkel B, Zamora MP, Perez JI, Pita G, Alonso MR, Cox A, Brock IW, Cross SS, Reed MW, Sawyer EJ, Tomlinson I, Kerin MJ, Miller N, Henderson BE, Schumacher F, Le Marchand L, Andrulis IL, Knight JA, Glendon G, Mulligan AM; kConFab Investigators; stralian Ovarian Cancer Study Group, Lindblom A, Margolin S, Hooning MJ, Hollestelle A, van den Ouweland AM, Jager A, Bui QM, Stone J, Dite GS, Apicella C, Tsimiklis H, Giles GG, Severi G, Baglietto L, Fasching PA, Haeberle L, Ekici AB, Beckmann MW, Brenner H, Müller H, Arndt V, Stegmaier C, Swerdlow A, Ashworth A, Orr N, Jones M, Figueroa J, Lissowska J, Brinton L, Goldberg MS, Labrèche F, Dumont M, Winqvist R, Pylkäs K, Jukkola-Vuorinen A, Grip M, Brauch H, Hamann U, Brüning T; GENICA (Gene Environment Interaction and Breast Cancer in Germany) Network, Radice P, Peterlongo P, Manoukian S, Bonanni B, Devilee. "Large-scale genotyping identifies 41 new loci associated with breast cancer risk." Nature Genetics. Vol. 45, no. 4. (March 2013.): 353-361.

Couch FJ, Wang X, McGuffog L, Lee A, Olswold C, Kuchenbaecker KB, Soucy P, Fredericksen Z, Barrowdale D, Dennis J, Gaudet MM, Dicks E, Kosel M, Healey S, Sinilnikova OM, Lee A, Bacot F, Vincent D, Hogervorst FB, Peock S, Stoppa-Lyonnet D, Jakubowska A, Investigators K, Radice P, Schmutzler RK; SWE-BRCA, Domchek SM, Piedmonte M, Singer CF, Friedman E, Thomassen M; Ontario Cancer Genetics Network, Hansen TV, Neuhausen SL, Szabo CI, Blanco I, Greene MH, Karlan BY, Garber J, Phelan CM, Weitzel JN, Montagna M, Olah E, Andrulis IL, Godwin AK, Yannoukakos D, Goldgar DE, Caldes T, Nevanlinna H, Osorio A, Terry MB, Daly MB, van Rensburg EJ, Hamann U, Ramus SJ, Ewart Toland A, Caligo MA, Olopade OI, Tung N, Claes K, Beattie MS, Southey MC, Imyanitov EN, Tischkowitz M, Janavicius R, John EM, Kwong A, Diez O, Balmaña J, Barkardottir RB, Arun BK, Rennert G, Teo SH, Ganz PA, Campbell I, van der Hout AH, van Deurzen CH, Seynaeve C, Gómez Garcia EB, van Leeuwen FE, Meijers-Heijboer HE, Gille JJ, Ausems MG, Blok MJ, Ligtenberg MJ, Rookus MA, Devilee P, Verhoef S, van Os TA, Wijnen JT; HEBON; EMBRACE, Frost D, Ellis S, Fineberg E, Platte R, Evans DG, Izatt L, Eeles RA, Adlard J, Eccles DM, Cook J, Brewer C, Douglas F, Hodgson S, Morrison PJ, Side LE, Donaldson A, Houghton C, Rogers MT, Dorkins H, Eason J, Gregory H, McCann E, Murray A, Calender A, Hardouin A, Berthet P, Delnatte C, Nogues C, Lasset C, Houdayer C, Leroux D, Rouleau E, Prieur F, Damiola F, Sobol H, Coupier I, Venat-Bouvet L, Castera L, Gauthier-Villars M, Léoné M, Pujol P, Mazoyer S, Bignon YJ; GEMO Study Collaborators, Złowocka-Perłowska E, Gronwald J, Lubinski J, Durda K, Jaworska K, Huzarski T, Spurdle AB, Viel A, Peissel B, Bonanni B, Melloni G, Ottini L, Papi L, Varesco L, Tibiletti MG, Peterlongo P, Volorio S, Manoukian S, Pensotti V, Arnold N, Engel C, Deissler H, Gadzicki D, Gehrig A, Kast K, Rhiem K, Meindl A, Niederacher D, Ditsch N, Plendl H, Preisler-Adams S, Engert S, Sutter C, Varon-Mateeva R, Wappenschm. "Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk.." PLoS Genetics. Vol. 9, no. 3. (March 2013.): e1003212-.

French JD, Ghoussaini M, Edwards SL, Meyer KB, Michailidou K, Ahmed S, Khan S, Maranian MJ, O'Reilly M, Hillman KM, Betts JA, Carroll T, Bailey PJ, Dicks E, Beesley J, Tyrer J, Maia AT, Beck A, Knoblauch NW, Chen C, Kraft P, Barnes D, González-Neira A, Alonso MR, Herrero D, Tessier DC, Vincent D, Bacot F, Luccarini C, Baynes C, Conroy D, Dennis J, Bolla MK, Wang Q, Hopper JL, Southey MC, Schmidt MK, Broeks A, Verhoef S, Cornelissen S, Muir K, Lophatananon A, Stewart-Brown S, Siriwanarangsan P, Fasching PA, Loehberg CR, Ekici AB, Beckmann MW, Peto J, Dos Santos Silva I, Johnson N, Aitken Z, Sawyer EJ, Tomlinson I, Kerin MJ, Miller N, Marme F, Schneeweiss A, Sohn C, Burwinkel B, Guénel P, Truong T, Laurent-Puig P, Menegaux F, Bojesen SE, Nordestgaard BG, Nielsen SF, Flyger H, Milne RL, Zamora MP, Arias Perez JI, Benitez J, Anton-Culver H, Brenner H, Müller H, Arndt V, Stegmaier C, Meindl A, Lichtner P, Schmutzler RK, Engel C, Brauch H, Hamann U, Justenhoven C; The GENICA Network, Aaltonen K, Heikkilä P, Aittomäki K, Blomqvist C, Matsuo K, Ito H, Iwata H, Sueta A, Bogdanova NV, Antonenkova NN, Dörk T, Lindblom A, Margolin S, Mannermaa A, Kataja V, Kosma VM, Hartikainen JM; kConFab Investigators, Wu AH, Tseng CC, Van Den Berg D, Stram DO, Lambrechts D, Peeters S, Smeets A, Floris G, Chang-Claude J, Rudolph A, Nickels S, Flesch-Janys D, Radice P, Peterlongo P, Bonanni B, Sardella D, Couch FJ, Wang X, Pankratz VS, Lee A, Giles GG, Severi G, Baglietto L, Haiman CA, Henderson BE, Schumacher F, Le Marchand L, Simard J, Goldberg MS, Labrèche F, Dumont M, Teo SH, Yip CH, Ng CH, Vithana EN, Kristensen V, Zheng W, Deming-Halverson S, Shrubsole M, Long J, Winqvist R, Pylkäs K, Jukkola-Vuorinen A, Grip M, Andrulis IL, Knight JA, Glendon G, Mulligan AM, Devilee P, Seynaeve C, García-Closas M, Figueroa J, Chanock SJ, Lissowska J, Czene K, Klevebring D, Schoof N, Hooning MJ, Martens JW, Collée JM, Tilanus-Linthorst M, Hall P, Li J, Liu J, Humphreys K, Shu XO, Lu W, Gao YT, Cai H, Co. "Functional variants at the 11q13 risk locus for breast cancer regulate cyclin D1 expression through long-range enhancers." American Journal of Human Genetics. Vol. 92, no. 4. (April 2013.): 489-503.

Fleming JL, Gable GL, Samadzadeh-Tarihat S, Cheng L, Yu L, Gillespie JL, Toland AE. "Differential expression of miR-1, a putative tumor suppressing microRNA, in cancer resistant and cancer susceptible mice." PeerJ. Vol. 1, (April 2013.): e68-.

Hatem A, Bozdag D, Toland AE, Catalyürek UV. "Benchmarking short sequence mapping tools." BMC Bioinformatics. Vol. 14, no. 1. (June 2013.): 184-.

Senter L, O'Connor M, Oriyo F, Sweet K, Toland AE. "Linking distant relatives with BRCA gene mutations: potential for cost savings." Clin Genet. Vol. 85, no. 1. (May 2013.): 54-58.

Hemminger JA, Ewart Toland A, Scharschmidt TJ, Mayerson JL, Kraybill WG, Guttridge DC, Iwenofu OH. "The cancer-testis antigen NY-ESO-1 is highly expressed in myxoid and round cell subset of liposarcomas." Modern Pathology. Vol. 26, no. 2. (February 2013.): 282-288.

Skeeles LE, Fleming JL, Mahler KL, Toland AE. "The impact of 3'UTR variants on differential expression of candidate cancer susceptibility genes." PLoS One. Vol. 8, no. 3. (March 2013.): e58609-.

Milne RL, Herranz J, Michailidou K, Dennis J, Tyrer JP, Zamora MP, Arias-Perez JI, González-Neira A, Pita G, Alonso MR, Wang Q, Bolla MK, Czene K, Eriksson M, Humphreys K, Darabi H, Li J, Anton-Culver H, Neuhausen SL, Ziogas A, Clarke CA, Hopper JL, Dite GS, Apicella C, Southey MC, Chenevix-Trench G; kConFab Investigators; Australian Ovarian Cancer Study Group, Swerdlow A, Ashworth A, Orr N, Schoemaker M, Jakubowska A, Lubinski J, Jaworska-Bieniek K, Durda K, Andrulis IL, Knight JA, Glendon G, Mulligan AM, Bojesen SE, Nordestgaard BG, Flyger H, Nevanlinna H, Muranen TA, Aittomäki K, Blomqvist C, Chang-Claude J, Rudolph A, Seibold P, Flesch-Janys D, Wang X, Olson JE, Vachon C, Purrington K, Winqvist R, Pylkäs K, Jukkola-Vuorinen A, Grip M, Dunning AM, Shah M, Guénel P, Truong T, Sanchez M, Mulot C, Brenner H, Dieffenbach AK, Arndt V, Stegmaier C, Lindblom A, Margolin S, Hooning M, Hollestelle A, Collée M, Jager A, Cox A, Brock IW, Reed MW, Devilee P, Tollenaar RA, Seynaeve C, Haiman CA, Henderson BE, Schumacher F, Le Marchand L, Simard J, Dumont M, Soucy P, Dörk T, Bogdanova NV, Hamann U, Försti A, Rüdiger T, Ulmer HU, Fasching PA, Häberle L, Ekici AB, Beckmann MW, Fletcher O, Johnson N, Silva ID, Peto J, Radice P, Peterlongo P, Peissel B, Mariani P, Giles GG, Severi G, Baglietto L, Sawyer E, Tomlinson I, Kerin M, Miller N, Marme F, Burwinkel B, Mannermaa A, Kataja V, Kosma VM, Hartikainen J, Lambrechts D, Yesilyurt BT, Floris G, Leunen K, Alnæs GG, Kristensen V, Børresen-Dale AL, García-Closas M, Chanock SJ, Lissowska J, Figueroa JD, Schmidt MK, Broeks A, Verhoef S, Rutgers EJ, Brauch H, Brüning T, Ko YD; The GENICA Network, Couch FJ, Toland AE; The TNBCC, Yannoukakos D, Pharoah PD, Hall P, Benítez J, Malats N, Easton DF.. "A large-scale assessment of two-way SNP interactions in breast cancer susceptibility using 46,450 cases and 42,461 controls from the breast cancer association consortium.." Hum Mol Genet. Vol. 23, no. 7. (April 2014.): 1934-1946.

Fleming JL, Dworkin AM, Allain DC, Fernandez S, Wei L, Peters SB, Iwenofu OH, Ridd K, Bastian BC, Toland AE. "Allele-specific imbalance mapping identifies HDAC9 as a candidate gene for cutaneous squamous cell carcinoma." Int J Cancer. Vol. 134, no. 1. (January 2014.): 244-248.

Hemminger JA, Toland AE, Scharschmidt TJ, Mayerson JL, Guttridge DC, Iwenofu OH.. "Expression of cancer-testis antigens MAGEA1, MAGEA3, ACRBP, PRAME, SSX2, and CTAG2 in myxoid and round cell liposarcoma.." Modern Pathology. Vol. Epub, (January 2014.): Epub-.

Lea SC, Efird JT, Toland AE, Lewis DR, Phillips CJ.. "Melanoma incidence rates in active duty military personnel compared with a population-based registray in the United States.." Military Medicine. Vol. 179, no. 3. (March 2014.): 247-253.

Deveci M, Catalyürek UV, Toland AE. "mr SNP: Software to detect SNP effects on microRNA binding." BMC Bioinformatics. Vol. 15, no. 1. (March 2014.): 73-.

Osorio A, Milne RL, Kuchenbaecker K, Vaclová T, Pita G, Alonso R, Peterlongo P, Blanco I, de la Hoya M, Duran M, Díez O, Ramón Y Cajal T, Konstantopoulou I, Martínez-Bouzas C, Andrés Conejero R, Soucy P, McGuffog L, Barrowdale D, Lee A, Swe-Brca, Arver B, Rantala J, Loman N, Ehrencrona H, Olopade OI, Beattie MS, Domchek SM, Nathanson K, Rebbeck TR, Arun BK, Karlan BY, Walsh C, Lester J, John EM, Whittemore AS, Daly MB, Southey M, Hopper J, Terry MB, Buys SS, Janavicius R, Dorfling CM, van Rensburg EJ, Steele L, Neuhausen SL, Ding YC, Hansen TV, Jønson L, Ejlertsen B, Gerdes AM, Infante M, Herráez B, Moreno LT, Weitzel JN, Herzog J, Weeman K, Manoukian S, Peissel B, Zaffaroni D, Scuvera G, Bonanni B, Mariette F, Volorio S, Viel A, Varesco L, Papi L, Ottini L, Tibiletti MG, Radice P, Yannoukakos D, Garber J, Ellis S, Frost D, Platte R, Fineberg E, Evans G, Lalloo F, Izatt L, Eeles R, Adlard J, Davidson R, Cole T, Eccles D, Cook J, Hodgson S, Brewer C, Tischkowitz M, Douglas F, Porteous M, Side L, Walker L, Morrison P, Donaldson A, Kennedy J, Foo C, Godwin AK, Schmutzler RK, Wappenschmidt B, Rhiem K, Engel C, Meindl A, Ditsch N, Arnold N, Plendl HJ, Niederacher D, Sutter C, Wang-Gohrke S, Steinemann D, Preisler-Adams S, Kast K, Varon-Mateeva R, Gehrig A, Stoppa-Lyonnet D, Sinilnikova OM, Mazoyer S, Damiola F, Poppe B, Claes K, Piedmonte M, Tucker K, Backes F, Rodríguez G, Brewster W, Wakeley K, Rutherford T, Caldés T, Nevanlinna H, Aittomäki K, Rookus MA, van Os TA, van der Kolk L, de Lange JL, Meijers-Heijboer HE, van der Hout AH, van Asperen CJ, Gómez Garcia EB, Hoogerbrugge N, Collée JM, van Deurzen CH, van der Luijt RB, Devilee P, Hebon, Olah E, Lázaro C, Teulé A, Menéndez M, Jakubowska A, Cybulski C, Gronwald J, Lubinski J, Durda K, Jaworska-Bieniek K, Johannsson OT, Maugard C, Montagna M, Tognazzo S, Teixeira MR, Healey S, Investigators K, Olswold C, Guidugli L, Lindor N, Slager S, Szabo CI, Vijai J, Robson M, Kauff N, Zhang L, Rau-Murthy R, Fink-Retter A, Singe. "DNA glycosylases involved in base excision repair may be associated with cancer risk in BRCA1 and BRCA2 mutation carriers." PLoS Genetics. Vol. 10, no. 4. (April 2014.): e1004256-.

Agarwal D, Pineda S, Michailidou K, Herranz J, Pita G, Moreno LT, Alonso MR, Dennis J, Wang Q, Bolla MK, Meyer KB, Menéndez-Rodríguez P, Hardisson D, Mendiola M, González-Neira A, Lindblom A, Margolin S, Swerdlow A, Ashworth A, Orr N, Jones M, Matsuo K, Ito H, Iwata H, Kondo N; kConFab Investigators; Australian Ovarian Cancer Study Group, Hartman M, Hui M, Lim WY, Iau PT, Sawyer E, Tomlinson I, Kerin M, Miller N, Kang D, Choi J-, Park SK, Noh D-, Hopper JL, Schmidt DF, Makalic E, Southey MC, Teo SH, Yip CH, Sivanandan K, Tay W-, Brauch H, Brüning T, Hamann U; GENICA Network, Dunning AM, Shah M, Andrulis IL, Knight JA, Glendon G, Tchatchou S, Schmidt MK, Broeks A, Rosenberg EH, van't Veer LJ, Fasching PA, Renner SP, Ekici AB, Beckmann MW, Shen C-, Hsiung C-, Yu J-, Hou M-, Blot W, Cai Q, Wu AH, Tseng C-, Van Den Berg D, Stram DO, Cox A, Brock IW, Reed MW, Muir K, Lophatananon A, Stewart-Brown S, Siriwanarangsan P, Zheng W, Deming-Halverson S, Shrubsole MJ, Long J, Shu X-, Lu W, Gao Y-, Zhang B, Radice P, Peterlongo P, Manoukian S, Mariette F, Sangrajrang S, McKay J, Couch FJ, Toland AE; TNBCC, Yannoukakos D, Fletcher O, Johnson N, dos Santos Silva I, Peto J, Marme F, Burwinkel B, Guénel P, Truong T, Sanchez M, Mulot C, Bojesen SE, Nordestgaard BG, Flyer H, Brenner H, Dieffenbach AK, Arndt V, Stegmaier C, Mannermaa A, Kataja V, Kosma V-, Hartikainen JM, Lambrechts D, Yesilyurt BT, Floris G, Leunen K, Chang-Claude J, Rudolph A, Seibold P, Flesch-Janys D, Wang X, Olson JE, Vachon C, Purrington K, Giles GG, Severi G, Baglietto L, Haiman CA, Henderson BE, Schumacher F, Marchand LL, Simard J, Dumont M, Goldberg MS, Labréche F, Winqvist R, Pylkäs K, Jukkola-Vuorinen A, Grip M, Devilee P, Tollenaar RA, Seynaeve C, García-Closas M, Chanock SJ, Lissowska J, Figueroa JD, Czene K, Eriksson M, Humphreys K, Darabi H, Hooning MJ, Kriege M, Collée JM, Tilanus-Linthorst M, Li J, Jakubowska A, Lubinski J, Jaworska-Bieniek K, Durda K, Nevanlinna H, Muranen TA, Aittomäki K, Blomqvist C. "FGF receptor genes and breast cancer susceptibility: results from the Breast Cancer Association Consortium." Br J. Cancer. Vol. 110, no. 4. (February 2014.): 1088-1100.

Sweet K, Gordon E, Sturm A, Schmidlen T, Kandamurugu M, Toland A, Keller M, Stack C, Bellafanta M, Tayal N, Embi P, Binkley P, Hershberger R, Sadee W, Christman M, Marsh C, García-España JF.. "Design and implementation of a randomized study of genomic counseling." J Pers Med. Vol. 4, no. 1. (January 2014.): 1-19.

Johnson N, Dudbridge F, Orr N, Gibson L, Jones ME, Schoemaker MJ, Folkerd EJ, Haynes BP, Hopper JL, Southey MC, Dite GS, Apicella C, Schmidt MK, Broeks A, Van T Veer LJ, Atsma F, Muir K, Lophatananon A, Fasching PA, Beckmann MW, Ekici AB, Renner SP, Sawyer E, Tomlinson I, Kerin M, Miller N, Burwinkel B, Marme F, Schneeweiss A, Sohn C, Guénel P, Truong T, Cordina E, Menegaux F, Bojesen SE, Nordestgaard BG, Flyger H, Milne R, Zamora MP, Arias Perez JI, Benitez J, Bernstein L, Anton-Culver H, Ziogas A, Clarke Dur C, Brenner H, Müller H, Arndt V, Dieffenbach AK, Meindl A, Heil J, Bartram CR, Schmutzler RK, Brauch H, Justenhoven C, Ko YD, Nevanlinna H, Muranen TA, Aittomäki K, Blomqvist C, Matsuo K, Dörk T, Bogdanova NV, Antonenkova NN, Lindblom A, Mannermaa A, Kataja V, Kosma VM, Hartikainen JM, Chenevix-Trench G, Beesley J, Wu AH, Van den Berg D, Tseng CC, Lambrechts D, Smeets D, Neven P, Wildiers H, Chang-Claude J, Rudolph A, Nickels S, Flesch-Janys D, Radice P, Peterlongo P, Bonanni B, Pensotti V, Couch FJ, Olson JE, Wang X, Fredericksen Z, Pankratz VS, Giles GG, Severi G, Baglietto L, Haiman C, Simard J, Goldberg MS, Labrèche F, Dumont M, Soucy P, Teo S, Yip CH, Phuah SY, Cornes BK, Kristensen VN, Grenaker Alnæs G, Børresen-Dale AL, Zheng W, Winqvist R, Pylkäs K, Jukkola-Vuorinen A, Grip M, Andrulis IL, Knight JA, Glendon G, Mulligan AM, Devillee P, Figueroa J, Chanock SJ, Lissowska J, Sherman ME, Hall P, Schoof N, Hooning M, Hollestelle A, Oldenburg RA, Tilanus-Linthorst M, Liu J, Cox A, Brock IW, Reed MW, Cross SS, Blot W, Signorello LB, Pharoah PD, Dunning AM, Shah M, Kang D, Noh DY, Park SK, Choi JY, Hartman M, Miao H, Lim WY, Tang A, Hamann U, Försti A, Rüdiger T, Ulmer HU, Jakubowska A, Lubinski J, Jaworska-Bieniek K, Durda K, Sangrajrang S, Gaborieau V, Brennan P, McKay J, Slager S, Toland AE, Vachon C, Yannoukakos D, Shen CY, Yu JC, Huang CS, Hou MF, González-Neira A, Tessier DC, Vincent D, Bacot F, Luccarini C, Dennis J, Michailidou K, Bolla MK, Wang J, Ea. "Genetic variation at CYP3A is associated with age at menarche and breast cancer risk: a case-control study." Breast Cancer Res. Vol. 16, no. 3. (May 2014.): R51-.

Purrington KS, Slettedahl S, Bolla MK, Michailidou K, Czene K, Nevanlinna H, Bojesen SE, Andrulis IL, Cox A, Hall P, Carpenter J, Yannoukakos D, Haiman CA, Fasching PA, Mannermaa A, Winqvist R, Brenner H, Lindblom A, Chenevix-Trench G, Benitez J, Swerdlow A, Kristensen V, Guénel P, Meindl A, Darabi H, Eriksson M, Fagerholm R, Aittomäki K, Blomqvist C, Nordestgaard BG, Nielsen SF, Flyger H, Wang X, Olswold C, Olson JE, Mulligan AM, Knight JA, Tchatchou S, Reed MW, Cross SS, Liu J, Li J, Humphreys K, Clarke C, Scott R; ABCTB Investigators, Fostira F, Fountzilas G, Konstantopoulou I, Henderson BE, Schumacher F, Le Marchand L, Ekici AB, Hartmann A, Beckmann MW, Hartikainen JM, Kosma VM, Kataja V, Jukkola-Vuorinen A, Pylkäs K, Kauppila S, Dieffenbach AK, Stegmaier C, Arndt V, Margolin S; Australian Ovarian Cancer Study Group; kConFab Investigators, Balleine R, Arias Perez JI, Zamora MP, Menéndez P, Ashworth A, Jones M, Orr N, Arveux P, Kerbrat P, Truong T, Bugert P, Toland AE, Ambrosone CB, Labrèche F, Goldberg MS, Dumont M, Ziogas A, Lee E, Dite GS, Apicella C, Southey MC, Long J, Shrubsole M, Deming-Halverson S, Ficarazzi F, Barile M, Peterlongo P, Durda K, Jaworska-Bieniek K, Tollenaar RA, Seynaeve C; The GENICA Network, Brüning T, Ko YD, van Deurzen CH, Martens JW, Kriege M, Figueroa JD, Chanock SJ, Lissowska J, Tomlinson I, Kerin MJ, Miller N, Schneeweiss A, Tapper WJ, Gerty SM, Durcan L, McLean C, Milne RL, Baglietto L, Dos Santos Silva I, Fletcher O, Johnson N, Van't Veer LJ, Cornelissen S, Försti A, Torres D, Rüdiger T, Rudolph A, Flesch-Janys D, Nickels S, Weltens C, Floris G, Moisse M, Dennis J, Wang Q, Dunning AM, Shah M, Brown J, Simard J, Anton-Culver H, Neuhausen SL, Hopper JL, Bogdanova N, Dörk T, Zheng W, Radice P, Jakubowska A, Lubinski J, Devillee P, Brauch H, Hooning M, García-Closas M, Sawyer E, Burwinkel B, Marmee F, Eccles DM, Giles GG, Peto J, Schmidt M, Broeks A, Hamann U, Chang-Claude J, Lambrechts D, Pharoah PD, Easton D, Pankratz VS, Slager S,. "Genetic variation in mitotic regulatory pathway genes is associated with breast tumor grade." Hum Mol Genet. Vol. Epub, (June 2014.): Epub-.

Purrington KS, Slager S, Eccles D, Yannoukakos D, Fasching PA, Miron P, Carpenter J, Chang-Claude J, Martin NG, Montgomery GW, Kristensen V, Anton-Culver H, Goodfellow P, Tapper WJ, Rafiq S, Gerty SM, Durcan L, Konstantopoulou I, Fostira F, Vratimos A, Apostolou P, Konstanta I, Kotoula V, Lakis S, Dimopoulos MA, Skarlos D, Pectasides D, Fountzilas G, Beckmann MW, Hein A, Ruebner M, Ekici AB, Hartmann A, Schulz-Wendtland R, Renner SP, Janni W, Rack B, Scholz C, Neugebauer J, Andergassen U, Lux MP, Haeberle L, Clarke C, Pathmanathan N, Rudolph A, Flesch-Janys D, Nickels S, Olson JE, Ingle JN, Olswold C, Slettedahl S, Eckel-Passow JE, Anderson SK, Visscher DW, Cafourek V, Sicotte H, Prodduturi N, Weiderpass E, Bernstein L, Ziogas A, Ivanovich J, Giles GG, Baglietto L, Southey M, Kosma VM, Fischer HP, Network TG, Reed MW, Cross SS, Deming-Halverson S, Shrubsole M, Cai Q, Shu XO, Daly M, Weaver J, Ross E, Klemp J, Sharma P, Torres D, Rüdiger T, Wölfing H, Ulmer HU, Försti A, Khoury T, Kumar S, Pilarski R, Shapiro CL, Greco D, Heikkilä P, Aittomäki K, Blomqvist C, Irwanto A, Liu J, Pankratz VS, Wang X, Severi G, Mannermaa A, Easton D, Hall P, Brauch H, Cox A, Zheng W, Godwin AK, Hamann U, Ambrosone C, Toland AE, Nevanlinna H, Vachon CM, Couch FJ.. "Genome-wide association study identifies 25 known breast cancer susceptibility loci as risk factors for triple negative breast cancer." Carcinogenesis. Vol. 35, no. 5. (May 2014.): 1012-1019.

Milne RL, Burwinkel B, Michailidou K, Arias-Perez JI, Zamora MP, Menéndez-Rodríguez P, Hardisson D, Mendiola M, González-Neira A, Pita G, Alonso MR, Dennis J, Wang Q, Bolla MK, Swerdlow A, Ashworth A, Orr N, Schoemaker M, Ko YD, Brauch H, Hamann U; The GENICA Network, Andrulis IL, Knight JA, Glendon G, Tchatchou S, Investigators K; Australian Ovarian Cancer Study Group, Matsuo K, Ito H, Iwata H, Tajima K, Li J, Brand JS, Brenner H, Dieffenbach AK, Arndt V, Stegmaier C, Lambrechts D, Peuteman G, Christiaens MR, Smeets A, Jakubowska A, Lubinski J, Jaworska-Bieniek K, Durda K, Hartman M, Hui M, Lim WY, Chan CW, Marme F, Yang R, Bugert P, Lindblom A, Margolin S, García-Closas M, Chanock SJ, Lissowska J, Figueroa JD, Bojesen SE, Nordestgaard BG, Flyger H, Hooning MJ, Kriege M, van den Ouweland AM, Koppert LB, Fletcher O, Johnson N, Dos-Santos-Silva I, Peto J, Zheng W, Deming-Halverson S, Shrubsole MJ, Long J, Chang-Claude J, Rudolph A, Seibold P, Flesch-Janys D, Winqvist R, Pylkäs K, Jukkola-Vuorinen A, Grip M, Cox A, Cross SS, Reed MW, Schmidt MK, Broeks A, Cornelissen S, Braaf L, Kang D, Choi JY, Park SK, Noh DY, Simard J, Dumont M, Goldberg MS, Labrèche F, Fasching PA, Hein A, Ekici AB, Beckmann MW, Radice P, Peterlongo P, Azzollini J, Barile M, Sawyer E, Tomlinson I, Kerin M, Miller N, Hopper JL, Schmidt DF, Makalic E, Southey MC, Teo SH, Yip CH, Sivanandan K, Tay WT, Shen CY, Hsiung CN, Yu JC, Hou MF, Guénel P, Truong T, Sanchez M, Mulot C, Blot W, Cai Q, Nevanlinna H, Muranen TA, Aittomäki K, Blomqvist C, Wu AH, Tseng CC, Van Den Berg D, Stram DO, Bogdanova N, Dörk T, Muir K, Lophatananon A, Stewart-Brown S, Siriwanarangsan P, Mannermaa A, Kataja V, Kosma VM, Hartikainen JM, Shu XO, Lu W, Gao YT, Zhang B, Couch FJ, Toland AE; TNBCC, Yannoukakos D, Sangrajrang S, McKay J, Wang X, Olson JE, Vachon C, Purrington K, Severi G, Baglietto L, Haiman CA, Henderson BE, Schumacher F, Le Marchand L, Devilee P, Tollenaar RA, Seynaeve C, Czene K, Eriksson M, Humphreys K, Darabi. "Common non-synonymous SNPs associated with breast cancer susceptibility: findings from the Breast Cancer Association Consortium." Human Molecular Genetics. Vol. Epub, (June 2014.): Epub-.

 

Reference Works

October 1995 Frangiskakis JM, Ewart AK, Morris CA et al.."WS2 hemizygosity may contribute to the Williams-syndrome cognitive phenotype" Minneapolis. : S:1383
January 1998 Ewart-Toland A, Enns GM, Cox VA et al.."Caroli's disease and severe renal anomalies in individuals with Kabuki syndrome" ?. : 130A
October 1998 Ewart-Toland A, Chehab FF."Identification of fertility modifiers using leptin deficient ob/ob mice" Denver.
January 2000 Toland, AE, de Koning J, Mao J-H, Conrad, P, Balmain, A.."The search for cancer modifier genes using single nucleotide polymorphisms at human chromosome 20q13.2." .
October 2000 Toland AE, de Koning J, Mao J et al.."The search for cancer modifier genes using single nucleotide polymorphisms at human chromosome 20q13.2" Chicago. : 331
January 2001 McLennan JL, Crawford EB, Toland AE, Ziegler JL, Tripathy D, Esserman LJ.."Risk reduction behavior in individuals and families at high risk for breast/ovarian syndrome." .
January 2002 Chiaverotti, T, Ewart Toland A, Chan J, Ma J, Albertson D, Donjacour A, Huey B, Cunha G.."Identification of Prostate Cancer Susceptibility genes using mouse models of cancer" .
January 2004 Ewart-Toland A, Chiaverotti T, Chan J, Ma J, Huey B, Albertson D, Balmain A.."Identification of prostate cancer genes using mouse models of cancer." .
January 2005 Ewart Toland, A, McClennan J Ziegler J.."The role of BRCA1 and 2 variants in breast cancer risk" .
April 2006 Toland AE, McClennan J, Fridlyand J, Ziegler J.."Using tumor characteristics to classify BRCA1 & 2 variants of uncertain significance" .
February 2006 Cooper K, McGrath, R, Cho H-Y, and Toland, AE.."Identification of candidate genes for mouse skin tumor susceptibility 5 (Skts5)." .
October 2006 Toland, AE, Cooper KL, Dworkin A, Gladman NP, Cho H-Y, Mao J-H, Balmain A.."Sequence divergence between Mus Spretus and Mus Musculus across a 13Mb region on chromosome 12." .
January 2007 Dworkin AM, Bautista D, Ridd K, Pinkel D, Bastian B, Toland AE.."The use of preferential imbalance to identify skin cancer susceptibility loci." .
January 2007 Dworkin A, Bastian B, Toland A.."The use of preferential imbalance to identify skin cancer susceptibility loci." .
October 2007 Ewart-Toland A, Mounzih K, Chehab FF."Dissociation of the fertility and obesity phenotypes in genetically hetergenous obese mice" San Francisco. : A250
October 2007 Dworkin AM, Bautista D, Ridd K, Pinkel D, Bastian B, Toland AE."The use of preferential imbalance to identify skin cancer susceptibility loci. American Society of Human Genetics" .
January 2007 Toland AE.."Identification of Aurora-A interacting genes at Skts5." .
January 2007 Mahler KL, Dworkin A, Gladman NP, Mao J-H, Balmain, A, Toland AE.."Integrated approaches to identify Aurora-A interacting susceptibility genes." .
January 2007 Fleming J, Mahler, K, Mao J-H, Balmain, A, Toland, AE.."Testing candidate genes for a role in squamous cell carcinoma susceptibility." .
January 2008 Spearman AD, Sweet K, Zhou XP, McClennan J, Couch FJ, Toland AE.."Deciphering the clinical significance of BRCA variants." .
January 2008 Dworkin AM, Bautista D, Ridd K, Pinkel D, Bastian B, Toland AE.."The use of preferential imbalance to identify skin cancer susceptibility loci." .
April 2008 Moeller L, Toland AE.."Identification of a potential regulatory mechanism for Aurora-A kinase expression." .
January 2008 Fleming J, Mahler, K, Mao J-H, Balmain, A, Toland, AE.."Testing candidates genes for a role in squamous cell carcinoma susceptibility." .
April 2008 Spearman AD, Sweet K, Zhou XP, McClennan J, Couch FJ, Toland AE."Deciphering the clinical significance of BRCA variants." .
October 2008 Toland AE, Dworkin AM.."Non-recipient DNA in squamous cell carcinomas of transplant patients." .
April 2009 Gable D, Fleming J, Toland AE.."The role of microRNA-1 as a tumor suppressor in cutaneous squamous cell carcinoma." .
April 2009 Fleming JL, Mahler KL, Skeeles LE, Mao JH, Balmain A, Toland AE.."Testing Ahr and Hdac9 for a Role in Cutaneous Squamous Cell Carcinoma Susceptibility." .
April 2009 Dworkin AM, Tober KL, Duncan FJ, Yu L, Van Buskirk AM, Oberyszyn TM, Toland AE.."Chromosomal aberrations in UVB-induced tumors of immunosuppressed mice." .
May 2009 Gable D, Fleming J, Toland AE.."The role of microRNA-1 as a tumor suppressor in cutaneous squamous cell carcinoma." .
April 2009 Sweet K, Senter LJ, Pilarski R, Toland AE.."Classifying BRCA1 ring finger variants." .
May 2009 Tseng SY, Dworkin AM, Toland AE.."Identification of Squamous Cell Carcinoma Susceptibility Genes Using Homozygous Mapping." .
September 2009 Gable D, Fleming J, Toland AE."The role of microRNA-1 as a tumor suppressor gene in cutaneous squamous cell carcinoma" .
September 2009 Fleming, JL, Mahler, K, Skeeles, LE, Mao, JH, Balmain, A, Toland, AE."Testing Ahr and Hdac9 for a Role in Cutaneous Squamous Cell Carcinoma Susceptibility" .
September 2009 Dworkin AM, Bautista D, Ridd K, Bastian B, Toland AE."The Use of Preferential Imbalance to Identify Skin Cancer Susceptibility Loci" .
November 2009 Gable D, Fleming J, Toland AE."The role of microRNA-1 as a tumor suppressor in cutaneous squamous cell carcinoma." Chicago.
November 2009 Dworkin AM, Bautista D, Ridd K, Pinkel D, Bastian B, Toland AE."The Use of Preferential Imbalance to Identify Skin Cancer Susceptibility Loci" Bethesda.
February 2009 Fleming JL, Mahler KL, Skeeles LE, Mao JH, Balmain A, Toland AE.."Testing Ahr and Hdac9 for a Role in Cutaneous Squamous Cell Carcinoma Susceptibility." .
January 2009 Dworkin AM, Tober KL, Duncan FJ, Yu L, Van Buskirk AM, Oberyszyn TM, Toland AE.."Chromosomal aberrations in UVB-induced tumors of immunosuppressed mice." .
October 2010 Leigha Senter-Jamieson, Kevin Sweet, Sudhaa Gnanadesikan, David Newman, Amanda Ewart Toland."VUS Predict, a web based tool for classifying BRCA variants of uncertain significance" Dallas.
November 2010 Leigha Senter-Jamieson, Kevin Sweet, Sudhaa Gnanadesikan, David Newman, Amanda Ewart Toland."VUS Predict, a web based tool for classifying BRCA variants of uncertain significance" Washington.
May 2010 Tseng S, Dworkin AM, Toland AE."Homozygosity mapping to identify risk genes for squamous cell carcinoma" .
January 2010 Gable DL, Fleming JL, Toland AE."The role of microRNA-1 as a tumor suppressor gene in cutaneous squamous cell carcinoma" .
February 2010 Gray KM, Tseng SY, Skeeles LE Toland AE."Differential expression of AHR in cutaneous squamous cell carcinoma" .
February 2010 Fleming, JL, Mahler, K, Skeeles, LE, Mao, JH, Balmain, A, Toland, AE."Testing Ahr and Hdac9 for a Role in Cutaneous Squamous Cell Carcinoma Susceptibility" .
February 2010 Dworkin AM, Bautista D, Ridd K, Pinkel D, Bastian B, Toland AE."The use of preferential imbalance to identify skin cancer susceptibility loci" .
April 2010 Gray KM, Tseng SY, Skeeles LE, Toland AE."Differential expression of AHR in cutaneous squamous cell carcinoma" .
April 2010 Gable DL, Fleming JL, Toland AE."The transcription factor oncogene, Ets1, as a potential target of the tumor suppressor, microRNA-1, in cutaneous squamous cell carcinoma" .
April 2010 D'Souza A, Tseng SY, Fleming JL, Toland AE."Mapping candidate variants for squamous cell carcinoma susceptibility at Skts5" .
May 2010 Gray KM, Tseng SY, Skeeles LE Toland AE."Differential expression of AHR in cutaneous squamous cell carcinoma" .
May 2010 Gable D, Fleming JL, Toland AE."MicroRNA-1 as a Tumor Suppressor in Cutaneous Squamous Cell Carcinoma" .
November 2010 Gray KM, Dworkin AM, Fleming JL, Toland AE."The role of DcPs on mRNA splicing and stability in cutaneous squamous cell carcinoma" Research Triangle Park.
November 2010 Gable D, Fleming J, Toland AE."Ets1 as a potential target of miR-1 in cutaneous squamous cell carcinoma" Washington.
November 2010 Fleming JL, Skeeles L, Toland AE."Identification of Genetic Risk Factors for Cutaneous Squamous Cell Carcinoma Susceptibility on Chromosome 7" Washington.
February 2011 Zhou W, Peng Z, Shen R, Toland A, Teng M, Chao JR, Liu S, Liu Y, Wicha MS, Lin H-JL."A novel CpG island-containing BRCA1 distal promoter is associated with breast stem cells and survival upon doxorubicin treatment" Columbus.
April 2011 Bolton KL, Goh C, Ramus S, Goldgar D, Benitez J, Osorio A, Easton D, Peock S, Godwin A, Kwong A, Blanco I, kConFab Investigators, Goode E, Greene M, Loud J, Mai P, Toland A, Gore M, Olsson H, Neuhausen S, Moysich K, Beattie M, Sucheston L, Montagna M, Despierre E, Lambrechts D, Gross J, Walsh C, Karlan B, Chenevix-Trench G, Antoniou A, Pharoah."Genetic heterogeneity of ovarian cancer survival effects in BRCA1/2 germline mutations: a large multi-center study." Orlando.
October 2012 Thompson BA, Desachy G, Quinn J, Toland AE, Weiss LA, Rauen KA."Single Nucleotide Polymorphisms (SNPs) and cancer risk in individuals with Costello Syndrome" San Francisco.
October 2012 Senter L, O'Connor M, Toland AE."Connecting family branches through recurrent BRCA mutations" San Francisco.
March 2012 Jessica L. Fleming, Amy M. Dworkin, Mingfeng Zhang, Abrar A. Qureshi, Dawn C Allain, Soledad Fernandez, Lai Wei, Sara Peters, O. Hans Iwenofu, Katie Ridd, Boris C. Bastian, Jiali Han, Amanda Ewart Toland."Allelic specific imbalance mapping identifies HDAC9 as a candidate susceptibility gene for cutaneous squamous cell carcinoma" Columbus.
April 2012 Jessica L. Fleming, Amy M. Dworkin, Mingfeng Zhang, Abrar A. Qureshi, Dawn C Allain, Soledad Fernandez, Lai Wei, Sara Peters, O. Hans Iwenofu, Katie Ridd, Boris C. Bastian, Jiali Han, Amanda Ewart Toland."Allelic specific imbalance mapping identifies HDAC9 and IFRD1 as candidate susceptibility genes for cutaneous squamous cell carcinoma" .
April 2012 Gray K, Dworkin AM, Toland AE.."DCPS as a potential tumor suppressor in cutaneous squamous cell carcinoma." Columbus.
April 2012 Gray K, Dworkin AM, Toland AE.."DCPS as a potential tumor suppressor in cutaneous squamous cell carcinoma." Chicago.
April 2012 Gerber MM, Schulz NP, Deveci M, Hampel H, Catalyurek U, de la Chapelle A, Toland AE.."Identification of AURKA- and PTPRJ-interacting human colorectal cancer susceptibility loci." Columbus.
April 2012 Fleming JL, Dworkin AM, Zhang M, Qureshi A, Allain DC, Fernandez S, Wei L, Peters S, Owenofu IH, Ridd K, Bastian B, Han J, Toland AE.."Allele specific imbalance mapping identifies HDAC9 as a candidate susceptibility gene for cutaneous squamous cell carcinoma." Chicago.
May 2012 Gray K, Dworkin AM, Toland AE."DCPS as a potential tumor suppressor in cutaneous squamous cell carcinoma" Columbus.
June 2012 Fleming JL, Dworkin AM, Zhang M, Qureshi A, Allain DC, Fernandez S, Wei L, Peters S, Owenofu IH, Ridd K, Bastian B, Han J, Toland AE.."Allelic-specific imbalance mapping identifies HDAC9 and IFRD1 as candidate susceptibility genes for cutaneous squamous cell carcinoma" Columbus.
April 2012 Schulz N, Gerber M, Deveci M, Catalyurek U, Toland AE.."RNA-seq in mouse models as a tool to elucidate colon cancer susceptibility" Columbus.
March 2013 Siekmann T, Toland AE."Identification of an intronic enhancer in HDAC9 associated with differential skin tumor risk" Columbus.
April 2013 Siekmann T, Toland AE."Identification of an intronic enhancer in HDAC9 associated with differential skin tumor risk" Columbus.
April 2013 Gerber, MM, Schulz NP, Deveci M, Hampel H, Catalyurek U, de la Chapelle A, Toland AE."Mouse models and human allele-specific imbalance studies identify candidate genes for colorectal cancer susceptibility" Columbus.
April 2013 Gerber, MM, Schulz NP, Deveci M, Hampel H, Catalyurek U, de la Chapelle A, Toland AE."Identification of AURKA- and PTPRJ-interacting human colorectal cancer susceptibility alleles" Washington.
April 2013 Gerber, MM, Schulz NP, Deveci M, Hampel H, Catalyurek U, de la Chapelle A, Toland AE."Identification of AURKA- and PTPRJ-interacting human colorectal cancer susceptibility alleles" Columbus.
April 2013 Siekmann T, Toland AE."Identification of an intronic enhancer in HDAC9 associated with differential skin tumor risk" Columbus.
October 2013 Toland AE, Skeeles LE, Peters SB, Teknos T, Olencki T, Allain DC."microRNA expression profiling in metastatic cutaneous squamous cell carcinoma" Boston.
March 2014 Siekmann T, Toland AE."Variants in Hdac9 intronic enhancer as candidates for skin tumor susceptibility locus" Columbus.
April 2014 Gerber MM, Cianciollo M, Toland AE."Interacting Susceptibility Genes for Colorectal Cancer" Columbus.
April 2014 Cheng L, Fleming JL, Toland AE."The role of the aryl hydrocarbon receptor in UV-induced skin cancer" Columbus.
April 2014 Siekmann T, Toland AE."Variants in Hdac9 intronic enhancer as candidates for skin tumor susceptibility locus" Columbus.
March 2014 Cheng L, Fleming JL, Toland AE."The role of the aryl hydrocarbon receptor in UV-induced skin cancer." Columbus.

Presentations

"The role of elastin in Williams Syndrome." Presented at Williams Syndrome Association Regional Meeting, Minneapolis, MN. (October 1993)

"Identification of fertility modifiers using leptin deficient ob/ob mice; Abstract 308." Presented at Annual American Society of Human Genetics Meeting, Denver, CO, US|USA. (October 1998)

"Identification of fertility modifiers in genetically obese mice." Presented at UCSF Department of Pediatrics Grand Rounds, Melvin Grumbach Speaker, San Francisco, CA. (June 1999)

"Identification of fertility modifiers in genetically obese mice." Presented at UCSF Pediatric Department Annual Retreat, San Francisco, CA. (January 1999)

"Identification of human cancer susceptibility genes using mouse models." Presented at Gordon Conference "Cancer", Newport, RI, US|USA. (July 2001)

"Using a cross-species approach to identify Aurora-2 as a cancer susceptibility gene." Presented at UCSF Comprehensive Cancer Center Friday Seminar, . (June 2002)

"Cross-species approaches to the discovery of cancer susceptibility genes." Presented at Breast Oncology Program/Breast Spore Seminar Series, San Francisco, CA, US|USA. (October 2002)

"Using a cross-species approach to identify Aurora-2 as a cancer susceptibility gene." Presented at UCSF Comprehensive Cancer Center Retreat, Monterey, CA. (September 2002)

"Cross Species Approaches to the Discover of Cancer Susceptibility Genes." Presented at Jackson laboratories Discovery Strategies Conference Series, Portland, ME. (September 2002)

"Genetics of Cancer Susceptibility: From Mouse to Man." Presented at Society of Toxicologic Pathology Annual Meeting, Savannah, GA. (June 2003)

"STK15 and beyond: Using mouse models to identify human cancer susceptibility genes." Presented at UCSF Comprehensive Cancer Center Retreat, . (November 2003)

"Hereditary Breast and Ovarian Cancer: To test or not to test?." Presented at Sutter Cancer Center Sacramento, Grand Rounds, . (November 2003)

"Characterization of variants in high risk genes." Presented at UCSF Breast Oncology Program Seminar Series, San Francisco, CA, US|USA. (October 2004)

"Using model systems to identify STK15 as a low penetrance cancer susceptibility gene." Presented at UCSF Genetic Epidemiology Seminar Series, San Francisco, CA, US|USA. (June 2004)

"Cancer & Dysmorphic Syndrome: Unknown Etiology." Presented at Bay Area Genetics Retreat, San Francisco, CA, US|USA. (June 2004)

"Characterization of BRCA1 and BRCA2 variants." Presented at UCSF Breast Oncology Program Retreat, . (February 2004)

"What to expect: My experiences in the search for a tenure track position." Presented at UCSF Postdoctoral Careers Seminar Series, San Francisco, CA, US|USA. (February 2005)

"The Genetics of Cancer Risk: The now and the future." Presented at Department of Radiology Grand Rounds, San Francisco, CA. (February 2005)

"The role of BRCA variants in cancer risk." Presented at UCSF Breast Oncology Program Annual Retreat, San Francisco, CA, US|USA. (January 2005)

"Integrated approaches for the identification of Aurora-A interacting genes at Skts5." Presented at MVIMG Faculty Seminar [My first presentation after beginning my appointment at OSU]., Columbus, OH. (September 2005)

"Hereditary cancer and cancer syndromes." Presented at UCSF Medical Genetics Board Review, San Francisco, CA, US|USA. (March 2005)

"The genetics and genomics of squamous cell carcinoma in organ transplant recipients." Presented at Department of Transplant Surgery Grand Rounds, . (September 2006)

"The genetics of cutaneous SCC susceptibility: Clues from mice and human populations." Presented at MVIMG faculty seminar series, Columbus, OH, US|USA. (September 2007)

"The importance of genetic interactions in cancer risk." Presented at OSU CCC Cancer Control Monthly Seminar, . (November 2007)

"Aurora-A and interacting loci: a role in skin cancer susceptibility." Presented at Columbus Children's Hospital Seminar Series, . (February 2007)

"Using model systems for the identification of low-penetrance cancer susceptibility genes." Presented at MCDB Recruting Seminar, . (March 2007)

"Integrated approaches to identify Aurora-A interacting susceptibility genes." Presented at Approaches to Complex Pathways in Molecular Epidemiology [This is my first national presentation after beginning my appointment to OSU.], Albuquerque, NM, US|USA. (May 2007)

"The genetics of SCC susceptibility: Clues from mice and high risk populations." Presented at Department of Dermatology skin cancer retreat, Columbus, OH. (April 2008)

"Non-recipient DNA in Squamous Cell Carcinomas of Transplant Patients." Presented at American Society of Human Genetics Annual Meeting, Philadelphia, PA, Philadelphia, PA, US|USA. (October 2008)

"A MVIMG (Viruses, Immunology & Genetics) Study of Susceptibility to Cutaneous SCC." Presented at MVIMG Faculty Seminar Series, . (January 2009)

"Susceptibility to Cutaneous SCC--Its not just the sun." Presented at OSU Department of Pathology Grand Rounds, . (March 2009)

"Susceptibility to cutaneous SCC: Genetic risk in the context of environmental factors." Presented at OSU Melanoma Group Meeting, . (May 2009)

"Beyond the Sun: Genetic and Immune Risk Factors for Cutaneous SCC." Presented at Helen Diller Cancer Center Friday Seminar Series, San Francisco, CA, US|USA. (September 2009)

"Using allele-specific somatic events to identify skin cancer susceptibility genes." Presented at UCSF Department of Medicine Division of Human Genetics Seminar, . (September 2010)

"Germline Variation Drives the Architecture of Somatic Alterations in Tumors." Presented at OSU Department of Pharmacology, . (October 2010)

"Using VUS Predict to classify BRCA variants of uncertain significance." Presented at Ohio Department of Health, Cancer Meeting, Polaris, OH. (April 2010)

"The role of donor cells in SCCs of organ transplant recipients." Presented at OSU Comprehensive Transplant Center, Columbus, OH, US|USA. (March 2011)

"Susceptibility to cutaneous SCC--Its not just the sun." Presented at Department of Biochemistry & Molecular Biology Seminar Series, Dayton, OH, US|USA. (November 2012)

"Allele-specific somatic alterations in cSCCs uncover tumor susceptibility genes." Presented at The 10th International Skin Carcinogenesis Conference, Columbus, OH, US|USA. (June 2012)

"Susceptibility to cutaneous SCC--Its not just the sun." Presented at Center for Genetics and Molecular Medicine Seminar Series, Louisville, KY, US|USA. (October 2012)

"Susceptibility to Cancer: How our genes impact cancer risk." Presented at Relating Science and Theology in Modern Society, Columbus. (December 2012)

"Genetics of Disease." Presented at CCTS Genomics Tools of the Trade, Columbus, UY|URY. (April 2013)

 

Professional Activities

present Site Visit Reviewer. American Cancer Society. Baltimore, MD.
2010 - present OSU Comprehensive Cancer Center American Cancer Society Seed Grants. Columbus, OH.
2010 - present "Beyond Risk" Conference. OSU Clinical Cancer Genetics. Columbus, OH.
2000 - 2001 Consultant for Genetic Health. Genetic Health.
2004 Dutch Cancer Society.
2008 Mentoring High School Student - Derren Huang. The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research Institute.
2008 National Institutes of Health; Colon Cancer Registry Resource Study Section. Bethesda, MD.
2007 - 2009 American Cancer Society-Ohio Division. Dublin, OH.
2009 Supported Centers for Population Health and Health Disparities (CPHHD) P50. National Institutes of Health/National Cancer Institute. Bethesda, MD.
2009 University of Arizona, Southwest Environmental Health Sciences Center..
2009 Vienna Science and Technology Fund (Wiener Wissenschafts-Foshungs- und Technologiefonds [WWTF]).
2009 Scottish Therapeutic Research Committee.
2009 - 2010 Italian Ministry of Health; Young Investigator Awards.
2009 - 2010 Dutch Cancer Society.
2010 Review of Molecular Biology Cancer Genetics grants. OSU CCC MBCG.
2010 Cancer Research UK.
2010 Medical Student Research Scholarship Applications. The Ohio State University College of Medicine Office of Research Education.
2011 Grant reviewer. National Health Laboratory Service Research Trust.
2012 Speaker at Beyond Risk conference for patients. OSU Cancer Genetics Program. Columbus, OH.
2012 Grant Review. Barts and the London Charity.
2009 - 2014 ACS Study Section. American Cancer Society, Tumor Biology and Genetics Study Section.. Atlanta, GA.